|
N°
|
MERCADO
RELEVANTE
|
CUM
|
MEDICAMENTO
|
TITULAR
|
PRECIO
MÁXIMO DE VENTA
|
|
1
|
3
|
19947558-1
|
VENTAVIS de 20 mcg en 2 mi; POLVO PARA INHALACION: x 30
|
BAYER PHARMA A.G.
|
$
2.474.660,84
|
|
2
|
3
|
19947558-2
|
VENTAVIS de 20 mcg en 2 mi; POLVO PARA INHALACION: x 90
|
BAYER PHARMA A.G.
|
$
7.423.982,53
|
|
3
|
4
|
20007747-1
|
FEIBA de 1000 Ul; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; x 1
|
BAXTER A.G.
|
$
2.621.773,02
|
|
4
|
4
|
20007747-2
|
FEIBA de 1000 Ul; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; x 1
|
BAXTER A.G.
|
$
2.621.773,02
|
|
5
|
4
|
226747-1
|
FEIBA de 500 Ul; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; x 1
|
BAXTER A.G.
|
$
1.310.886,52
|
|
6
|
4
|
226747-2
|
FEIBA de 500 Ul; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; x 1
|
BAXTER A.G.
|
$
1.310.886,52
|
|
7
|
4
|
226747-3
|
FEIBA de 500 Ul; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; x 1
|
BAXTER A.G.
|
$
1.310.886,52
|
|
8
|
4
|
226747-4
|
FEIBA de 500 Ul; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; x 1
|
BAXTER A.G.
|
$
1.310.886,52
|
|
9
|
6
|
20015482-1
|
NOVOSEVEN de 2mg (100 KUl); POLVO LIOFILIZADO PARA RECONSTITUIR
A SOLUCION INYECTABLE: x 1
|
NOVO NORDISK A/S
|
$
3,544,928,35
|
|
10
|
6
|
20021985-1
|
NOVOSEVEN de 1 mg (50 KUl); POLVOLIOFILIZADO PARA
RECONSTITUIR A SOLUCION INYECTABLE; x 1
|
NOVO NORDISK A/S
|
$
1.772.464,18
|
|
11
|
6
|
20021986-1
|
NOVOSEVEN de 5 mg (250 KUl); POLVO LIOFILIZADO PARA
RECONSTITUIR A SOLUCION INYECTABLE; x 1
|
NOVO NORDISK A/S
|
$
8.862.320,87
|
|
12
|
8
|
20001582-1
|
VOLIBRIS de 10 mg; TABLETA / CÁPSULA; x 30
|
GLAXOSMITHKLI NE TRADING SERVICES LIMITED
|
$
8.927.067,70
|
|
13
|
8
|
20001583-1
|
VOLIBRIS de 5 mg; TABLETA / CÁPSULA; x 30
|
GLAXOSMITHKLI NE TRADING SERVICES LIMITED
|
$
4.463.533,85
|
|
14
|
10
|
19941419-1
|
FORTEO de 750 mcg en 3 mi- 250mcg/ml; SOLUCION/SUSPENSIÓN
INYECTABLE; x 1
|
ELI LILLY AND COMPANY
|
$
970.038,05
|
|
15
|
10
|
19941419-2
|
FORTEO de 600 mcg en 2,4 mi - 250mcg/ml; SOLUCION/SUSPENSIÓN
INYECTABLE: x 1
|
ELI LILLY AND COMPANY
|
$
970.038,05
|
|
16
|
13
|
230435-1
|
SYNAGIS de 100 mg; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; x 1
|
ABBVIE S.A.S.
|
$
2.701.980,24
|
|
17
|
14
|
19907387-1
|
TEMODAL de 5 mg; TABLETA / CÁPSULA; x 5
|
MERCK SHARP & DOHME CORPORATION
|
$
54.704,67
|
|
18
|
14
|
19907387-2
|
TEMODAL de 5 mg; TABLETA / CÁPSULA; x 20
|
MERCK SHARP & DOHME CORPORATION
|
$
218.818,65
|
|
19
|
14
|
19907387-3
|
TEMODAL de 5 mg; TABLETA / CÁPSULA; x 5
|
MERCK SHARP & DOHME CORPORATION
|
$
54.704,67
|
|
20
|
14
|
19907387-4
|
TEMODAL de 5 mg; TABLETA / CÁPSULA; x 20
|
MERCK SHARP & DOHME CORPORATION
|
$
218.818,65
|
|
21
|
14
|
19907388-1
|
TEMODAL de 100 mg; TABLETA / CÁPSULA; x 5
|
MERCK SHARP & DOHME CORPORATION
|
$
1.094.093,23
|
|
22
|
14
|
19907388-2
|
TEMODAL de 100 mg; TABLETA / CÁPSULA; x 20
|
MERCK SHARP & DOHME CORPORATION
|
$
4.376.372,93
|
|
23
|
14
|
19907388-3
|
TEMODAL de 100 mg; TABLETA / CÁPSULA; x 5
|
MERCK SHARP & DOHME CORPORATION
|
$
1.094.093,23
|
|
24
|
14
|
19907388-4
|
TEMODAL de 100 mg; TABLETA / CÁPSULA; x 20
|
MERCK SHARP & DOHME CORPORATION
|
$
4.376.372,93
|
|
25
|
14
|
19907389-1
|
TEMODAL de 250 mg; TABLETA / CÁPSULA; x 5
|
MERCK SHARP & DOHME CORPORATION
|
$
2.735.233,08
|
|
26
|
14
|
19907389-2
|
TEMODAL de 250 mg; TABLETA / CÁPSULA; x 20
|
MERCK SHARP & DOHME CORPORATION
|
$
10.940.932,32
|
|
27
|
14
|
19907389-3
|
TEMODAL de 250 mg; TABLETA / CÁPSULA; x 5
|
MERCK SHARP & DOHME CORPORATION
|
$
2.735.233,08
|
|
28
|
14
|
19907389-4
|
TEMODAL de 250 mg; TABLETA / CÁPSULA; x 20
|
MERCK SHARP & DOHME CORPORATION
|
$
10.940.932,32
|
|
29
|
14
|
19907390-1
|
TEMODAL de 20 mg; TABLETA / CÁPSULA; x 5
|
MERCK SHARP & DOHME CORPORATION
|
$
218.818,65
|
|
30
|
14
|
19907390-2
|
TEMODAL de 20 mg; TABLETA / CÁPSULA; x 20
|
MERCK SHARP & DOHME CORPORATION
|
$
875.274,58
|
|
31
|
14
|
19907390-3
|
TEMODAL de 20 mg; TABLETA / CÁPSULA; x 5
|
MERCK SHARP & DOHME CORPORATION
|
$
218.818,65
|
|
32
|
14
|
19907390-4
|
TEMODAL de 20 mg; TABLETA / CÁPSULA; x 20
|
MERCK SHARP & DOHME CORPORATION
|
$
875.274,58
|
|
33
|
14
|
20001038-1
|
TEMODAL de 140 mg; TABLETA / CÁPSULA; x 5
|
MERCK SHARP & DOHME CORPORATION
|
$
1.531.730,53
|
|
34
|
14
|
20001038-2
|
TEMODAL de 140 mg; TABLETA / CÁPSULA; x 20
|
MERCK SHARP & DOHME CORPORATION
|
$
6.126.922,10
|
|
35
|
14
|
20001038-3
|
TEMODAL de 140 mg; TABLETA / CÁPSULA; x 5
|
MERCK SHARP & DOHME CORPORATION
|
$
1.531.730,53
|
|
36
|
14
|
20001038-4
|
TEMODAL de 140 mg; TABLETA / CÁPSULA; x 20
|
MERCK SHARP & DOHME CORPORATION
|
$
6.126.922,10
|
|
37
|
16
|
229745-1
|
XELODA de 500 mg; TABLETA / CÁPSULA; x 120
|
F. HOFFMANN -LA ROCHE LTD.
|
$
967.848,34
|
|
38
|
17
|
20010363-1
|
MABTHERA de 500 mg en 50 mi - lOmg/ml; SOLUCION/SUSPENSIÓN
INYECTABLE; x 1
|
F. HOFFMANN -LA ROCHE LTD.
|
$
3.442.788,95
|
|
39
|
17
|
226777-1
|
MABTHERA de 100 mg en 10 mi - lOmg/ml; SOLUCION/SUSPENSIÓN
INYECTABLE; x 2
|
F. HOFFMANN - LA ROCHE LTD.
|
$
1.377.115,58
|
|
40
|
17
|
226777-2
|
MABTHERA de 500 mg en 50 mi -10mg/ml; SOLUCION/SUSPENSIÓN
INYECTABLE; x 1
|
F. HOFFMANN -LA ROCHE LTD.
|
$
3.442.788,95
|
|
41
|
18
|
19903070-1
|
HERCEPTIN de 440 mg; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; x 1
|
F. HOFFMANN -LA ROCHE LTD.
|
$
4.693.285,09
|
|
42
|
19
|
19953428-1
|
ERBITUX de 250 mg en 50 mi; - 5mg/ml SOLUCION/ SUSPENSION
INYECTABLE; x 1
|
MERCK S.A.
|
$
1.692.682,78
|
|
43
|
19
|
19953428-2
|
ERBITUX de 500 mg en 100 mi; SOLUCION/ SUSPENSION
INYECTABLE; x 1
|
MERCK S.A.
|
$
3.385.365,56
|
|
44
|
19
|
19953428-3
|
ERBITUX de 100 mg en 20 mi 5mg/ml; SOLUCION PARA INFUSIÓN;
x 1
|
MERCK S.A.
|
$
677.073,12
|
|
45
|
20
|
19971195-1
|
NEXAVAR de 200 mg; TABLETA / CÁPSULA; x 10
|
BAYER PHARMA AG.
|
$
846.071,61
|
|
46
|
20
|
19971195-2
|
NEXAVAR de 200 mg; TABLETA / CÁPSULA; x 60
|
BAYER PHARMA AG.
|
$
5.076.429,64
|
|
47
|
22
|
19950318-1
|
VELCADE de 3,5 mg; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; x 1
|
JANSSEN CILAG S.A.
|
$
2.814.459,80
|
|
48
|
22
|
20054878-1
|
BORTEZOMIB de 3,5 mg; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; x 1
|
VENUS REMEDIES LIMITED
|
$
2.814.459,80
|
|
49
|
23
|
,19956000-1
|
AVASTIN de 100 mg en 4 mi- 25mg/ml; SOLUCION/SUSPENSIÓN
INYECTABLE; x 1
|
F. HOFFMANN -LA ROCHE LTD.
|
$
903.435,80
|
|
50
|
23
|
19956001-1
|
AVASTIN de 400 mg ; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; x 1
|
F. HOFFMANN -LA ROCHE LTD.
|
$
3.613.743,21
|
|
51
|
24
|
201182-1
|
ZOLADEX de 10,8 mg; IMPLANTE; x 1
|
ASTRAZENECA UK LIMITED
|
$
771.479,11
|
|
52
|
24
|
201182-3
|
ZOLADEX de 10,8 mg; IMPLANTE; x 1
|
ASTRAZENECA UK LIMITED
|
$
771.479,11
|
|
53
|
24
|
47155-1
|
ZOLADEX de 3,6 mg; IMPLANTE; x 1
|
ASTRAZENECA UK LIMITED
|
$
257.159,70
|
|
54
|
24
|
47155-3
|
ZOLADEX de 3,6 mg; IMPLANTE; x 1
|
ASTRAZENECA UK LIMITED
|
$
257.159,70
|
|
55
|
25
|
202595-1
|
BETAFERON de 250 mcg; SOLUCION/SUSPENSIÓN INYECTABLE; x 1
|
BAYER PHARMA AG.
|
$
156.497,28
|
|
56
|
25
|
202595-2
|
BETAFERON de 250 mcg; POLVO PARA RECONSTRUIR A
SOLUCION/SUSPENSIÓN INYECTABLE; X 15
|
BAYER PHARMA AG.
|
$
2.347.459,30
|
|
57
|
26
|
19905280-1
|
REMICADE de 100 mg; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; x 1
|
JANSSEN CILAG S.A.
|
$
1.276.136,14
|
|
58
|
27
|
20006016-1
|
TYSABRI de 300 mg en 15 mi - 20mg/ml; SOLUCION PARA
INFUSIÓN; x 1
|
BIOGEN IDEC LIMITED
|
$
4.258.883,34
|
|
59
|
28
|
20028870-1
|
SOLIRIS de 300 mg en 30 mi- lOmg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 1
|
ALEXION PHARMA COLOMBIA SAS
|
$
12.397.229,88
|
|
60
|
29
|
19939766-1
|
HUMIRA TM de 40 mg en 0,8 ml-50mg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 2
|
ABBVIE S.A.S.
|
$
2.540.069,22
|
|
61
|
29
|
19939766-2
|
HUMIRA TM de 40 mg en 0,8 mi- 50mg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 1
|
ABBVIES.A.S.
|
$
1.270.034,62
|
|
62
|
29
|
19939766-3
|
HUMIRA TM de 40 mg en 0,8 ml-50mg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 1
|
ABBVIE S.A.S.
|
$
1.270.034,62
|
|
63
|
29
|
19939766-4
|
HUMIRA TM de 40 mg en 0,8 ml-50mg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 2
|
ABBVIE S.A.S.
|
$
2.540.069,22
|
|
64
|
30
|
20014965-1
|
CIMZIA de 200 mg en 1 ml-200mg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 2
|
UCB PHARMA SA
|
$
2.301.205,58
|
|
65
|
30
|
20014965-2
|
CIMZIA de 200 mg en 1 ml-200mg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 6
|
UCB PHARMA SA
|
$
6.903.616,72
|
|
66
|
30
|
20014965-3
|
CIMZIA de 200 mg en 1 ml-200mg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 2
|
UCB PHARMA SA
|
$
2.301.205,58
|
|
67
|
30
|
20014965-4
|
CIMZIA de 200 mg en 1 ml-200mg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 6
|
UCB PHARMA SA
|
$
6.903.616,72
|
|
68
|
31
|
20002627-1
|
ACTEMRA de 200 mg en 10 ml-20mg/ml; SOLUCION/SUSPENSIÓN
INYECTABLE; X 1
|
F. HOFFMANN -LA ROCHE LTD.
|
$
949.987,47
|
|
69
|
31
|
20002627-2
|
ACTEMRA de 200 mg en 10 ml-20mg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 4
|
F. HOFFMANN -LA ROCHE LTD.
|
$
3.799.949,88
|
|
70
|
31
|
20002629-1
|
ACTEMRA de 80 mg en 4 ml-20mg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 1
|
F. HOFFMANN -LA ROCHE LTD.
|
$
379.994,98
|
|
71
|
31
|
20002629-2
|
ACTEMRA de 80 mg en 4 ml-20mg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 4
|
F. HOFFMANN -LA ROCHE LTD.
|
$
1.519.979,95
|
|
72
|
34
|
51881-1
|
SABRIL de 500 MG; TABLETA / CÁPSULA; x 60
|
SANOFI-AVENTIS DE COLOMBIA S.A.
|
$
84.724,81
|
|
73
|
34
|
51881-2
|
SABRIL de 500 MG; TABLETA / CÁPSULA; x 20
|
SANOFI-AVENTIS DE COLOMBIA S.A.
|
$
28.241,60
|
|
74
|
34
|
51881-4
|
SABRIL de 500 MG; TABLETA / CÁPSULA; x 90
|
SANOFI-AVENTIS DE COLOMBIA S.A.
|
$
127.087,22
|
|
75
|
37
|
19954847-2
|
REMINYL de 16 mg; CAPSULAS DE LIBERACIÓN MODIFICADA; x 7
|
JANSSEN CILAG S.A.
|
$
48.195,99
|
|
76
|
37
|
19954847-3
|
REMINYL de 16 mg; CAPSULAS DE LIBERACIÓN MODIFICADA; x 14
|
JANSSEN CILAG S.A.
|
$
96.391,98
|
|
77
|
37
|
19954847-4
|
REMINYL de 16 mg, CAPSULAS DE LIBERACIÓN MODIFICADA; x 28
|
JANSSEN CILAG S.A.
|
$
192.783,95
|
|
78
|
37
|
19954848-2
|
REMINYL de 8 mg; CAPSULAS DE LIBERACIÓN MODIFICADA; x 7
|
JANSSEN CILAG S.A.
|
$
24.097,99
|
|
79
|
37
|
19954848-3
|
REMINYL de 8 mg; CAPSULAS DE LIBERACIÓN MODIFICADA; X 14
|
JANSSEN CILAG S.A.
|
$
48.195,99
|
|
80
|
37
|
19954848-4
|
REMINYL de 8 mg; CAPSULAS DE LIBERACIÓN MODIFICADA; x 28
|
JANSSEN CILAG S.A.
|
$
96.391,98
|
|
81
|
38
|
19953339-1
|
XOLAIR de 150 mg; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; x 1
|
NOVARTIS PHARMAA.G.
|
$
975.959,91
|
|
82
|
39
|
19935648-1
|
SOMATULINE AUTOGEL de 90 mg en 0,3 ml-300 mg/ml-;
SOLUCION/SUSPENSIÓN INYECTABLE; x 1
|
IPSEN PHARMA S.A.S.
|
$
2.585.045,90
|
|
83
|
39
|
19935650-1
|
SOMATULINE AUTOGEL de 60 mg en 0,3 ml-200mg/ml-;
SOLUCION/SUSPENSIÓN INYECTABLE; X 1
|
IPSEN PHARMA S.A.S.
|
$
1.723.363,93
|
|
84
|
39
|
19995723-1
|
SOMATULINE de 120 mg en 0,5 mi- 240mg/ml-;
SOLUCION/SUSPENSIÓN INYECTABLE; x 1
|
IPSEN PHARMA S.A.S.
|
$
3.446.727,86
|
|
85
|
41
|
19927730-1
|
VALIXA de 450 mg; TABLETA / CÁPSULA; x 60
|
F. HOFFMANN -LA ROCHE LTD.
|
$
3.577.590,37
|
|
86
|
41
|
20011882-1
|
VANGAVIR de 450 mg; TABLETA / CÁPSULA; x 10
|
BIOTOSCANA FARMA S.A.
|
$
596.265,06
|
|
87
|
41
|
20011882-2
|
VANGAVIR de 450 mg; TABLETA / CÁPSULA; x 20
|
BIOTOSCANA FARMA S.A.
|
$
1.192.530,13
|
|
88
|
41
|
20011882-3
|
VANGAVIR de 450 mg; TABLETA / CÁPSULA; x 30
|
BIOTOSCANA FARMA S.A.
|
$
1.788.795,19
|
|
89
|
41
|
20011882-4
|
VANGAVIR de 450 mg; TABLETA / CÁPSULA; x 60
|
BIOTOSCANA FARMA S.A.
|
$
3.577.590,37
|
|
90
|
41
|
20011882-5
|
VANGAVIR de 450 mg; TABLETA / CÁPSULA; x 100
|
BIOTOSCANA FARMA S.A.
|
$
5.962.650,61
|
|
91
|
46
|
19983582-1
|
PROGRAF de 0,5 mg; CAPSULAS DE LIBERACIÓN MODIFICADA; X 50
|
JANSSEN CILAG S.A.
|
$
141.269,81
|
|
92
|
46
|
19983583-1
|
PROGRAF de 1 mg; CAPSULAS DE LIBERACIÓN MODIFICADA; x 50
|
JANSSEN CILAG S.A.
|
$
282.539,61
|
|
93
|
46
|
19983583-2
|
PROGRAF de 1 mg; CAPSULAS DE LIBERACIÓN MODIFICADA; x 100
|
JANSSEN CILAG S.A.
|
$
565.079,23
|
|
94
|
46
|
19983585-1
|
PROGRAF de 5 mg; CAPSULAS DE LIBERACION MODIFICADA; x 50
|
JANSSEN CILAG S.A.
|
$
1.412.698,08
|
|
95
|
46
|
19983585-2
|
PROGRAF de 5 mg; CAPSULAS DE LIBERACION MODIFICADA; X 100
|
JANSSEN CILAG S.A.
|
$
2.825.396,15
|
|
96
|
46
|
20035350-1
|
PROGRAF XL de 3 mg; CAPSULAS DE LIBERACION MODIFICADA; x 30
|
JANSSEN CILAG S.A.
|
$
508.571,31
|
|
97
|
46
|
20035350-2
|
PROGRAF XL de 3 mg; CAPSULAS DE LIBERACION MODIFICADA; X 50
|
JANSSEN CILAG S.A.
|
$
847.618,84
|
|
98
|
49
|
19909516-2
|
ZYVOXID de 600 mg; TABLETA / CÁPSULA; x 20
|
PFIZER S.A.S.
|
$
3.005.030,28
|
|
99
|
49
|
19909516-3
|
ZYVOXID de 600 mg; TABLETA / CÁPSULA; x 30
|
PFIZER S.A.S.
|
$
4.507.545,42
|
|
100
|
49
|
19909516-4
|
ZYVOXID de 600 mg; TABLETA / CÁPSULA; x 20
|
PFIZER S.A.S.
|
$
3.005.030,28
|
|
101
|
49
|
20045677-1
|
LINEZOLID de 600 mg; TABLETA / CÁPSULA; x 5
|
VESALIUS PHARMA S.A.S.
|
$
751.257,57
|
|
102
|
49
|
20045677-10
|
LINEZOLID de 600 mg; TABLETA / CÁPSULA; x 100
|
VESALIUS PHARMA S.A.S.
|
$
15.025.151,39
|
|
103
|
49
|
20045677-11
|
LINEZOLID de 600 mg; TABLETA / CÁPSULA; x 200
|
VESALIUS PHARMA S.A.S.
|
$
30.050.302,79
|
|
104
|
49
|
20045677-12
|
LINEZOLID de 600 mg; TABLETA / CÁPSULA; x 300
|
VESALIUS PHARMA S.A.S.
|
$
45.075.454,18
|
|
105
|
49
|
20045677-2
|
LINEZOLID de 600 mg; TABLETA / CÁPSULA; x 10
|
VESALIUS PHARMA S.A.S.
|
$
1.502.515,14
|
|
106
|
49
|
20045677-3
|
LINEZOLID de 600 mg; TABLETA / CÁPSULA; x 20
|
VESALIUS PHARMA S.A.S.
|
$
3.005.030,28
|
|
107
|
49
|
20045677-4
|
LINEZOLID de 600 mg; TABLETA / CÁPSULA; x 50
|
VESALIUS PHARMA S.A.S.
|
$
7.512.575,70
|
|
108
|
49
|
20045677-5
|
LINEZOLID de 600 mg; TABLETA / CÁPSULA; x 100
|
VESALIUS PHARMA S.A.S.
|
$
15.025.151,39
|
|
109
|
49
|
20045677-6
|
LINEZOLID de 600 mg; TABLETA / CÁPSULA; x 5
|
VESALIUS PHARMA S.A.S.
|
$
751.257,57
|
|
lio
|
49
|
20045677-7
|
LINEZOLID de 600 mg; TABLETA / CÁPSULA; x 10
|
VESALIUS PHARMA S.A.S.
|
$
1.502.515,14
|
|
111
|
49
|
20045677-8
|
LINEZOLID de 600 mg; TABLETA / CÁPSULA; x 20
|
VESALIUS PHARMA S.A.S.
|
$
3.005.030,28
|
|
112
|
49
|
20045677-9
|
LINEZOLID de 600 mg; TABLETA / CÁPSULA; x 50
|
VESALIUS PHARMA S.A.S.
|
$
7.512.575,70
|
|
113
|
50
|
19996372-1
|
VALIXA de 12 g; POLVO PARA RECONSTITUIR A SOLUCIÓN -
SUSPENSION ORAL; x 1
|
F. HOFFMANN -LA ROCHE LTD.
|
$
734.110,74
|
|
114
|
53
|
19988218-10
|
TASIGNA de 200 mg; TABLETA / CÁPSULA; x 40
|
NOVARTIS PHARMAA.G.
|
$
3.212.137,14
|
|
115
|
53
|
19988218-11
|
TASIGNA de 200 mg; TABLETA / CÁPSULA; x 28
|
NOVARTIS PHARMA A.G.
|
$
2.248.496,00
|
|
116
|
53
|
19988218-12
|
TASIGNA de 200 mg; TABLETA / CÁPSULA; x 112
|
NOVARTIS PHARMAA.G.
|
$
8.993.983,99
|
|
117
|
53
|
19988218-2
|
TASIGNA de 200 mg; TABLETA / CÁPSULA; x 28
|
NOVARTIS PHARMA A.G.
|
$
2.248.496,00
|
|
118
|
53
|
19988218-3
|
TASIGNA de 200 mg; TABLETA / CÁPSULA; x 28
|
NOVARTIS PHARMAA.G.
|
$
2.248.496,00
|
|
119
|
53
|
19988218-5
|
TASIGNA de 200 mg; TABLETA / CÁPSULA; x 112
|
NOVARTIS PHARMAA.G.
|
$
8.993.983,99
|
|
120
|
53
|
19988218-6
|
TASIGNA de 200 mg; TABLETA / CÁPSULA; x 112
|
NOVARTIS PHARMAA.G.
|
$
8.993.983,99
|
|
121
|
53
|
19988218-7
|
TASIGNA de 200 mg; TABLETA / CÁPSULA; x 120
|
NOVARTIS PHARMA A.G.
|
$
9.636.411,41
|
|
122
|
53
|
19988218-8
|
TASIGNA de 200 mg; TABLETA / CAPSULA; x 120
|
NOVARTIS PHARMA
|
$
9.636.411,41
|
|
123
|
53
|
19988218-9
|
TASIGNA de 200 mg; TABLETA / CÁPSULA; x 40
|
NOVARTIS PHARMAA.G.
|
$
3.212.137,14
|
|
124
|
53
|
20025951-1
|
TASIGNA de 150 mg; TABLETA / CÁPSULA; x 28
|
NOVARTIS PHARMAA.G.
|
$
1.686.372,00
|
|
125
|
53
|
20025951-2
|
TASIGNA de 150 mg; TABLETA / CÁPSULA; x 30
|
NOVARTIS PHARMAA.G.
|
$
1.806.827,14
|
|
126
|
53
|
20025951-3
|
TASIGNA de 150 mg; TABLETA / CÁPSULA; x 112
|
NOVARTIS PHARMAA.G.
|
$
6.745.487,99
|
|
127
|
53
|
20025951-4
|
TASIGNA de 150 mg; TABLETA / CÁPSULA; x 28
|
NOVARTIS PHARMAA.G.
|
$
1.686.372,00
|
|
128
|
53
|
20025951-5
|
TASIGNA de 150 mg; TABLETA / CÁPSULA; x 30
|
NOVARTIS PHARMAA.G.
|
$
1.806.827,14
|
|
129
|
53
|
20025951-6
|
TASIGNA de 150 mg; TABLETA / CÁPSULA; x 112
|
NOVARTIS PHARMAA.G.
|
$
6.745.487,99
|
|
130
|
53
|
20025951-7
|
TASIGNA de 150 mg; TABLETA / CÁPSULA; x 120
|
NOVARTIS PHARMAA.G.
|
$
7.227.308,56
|
|
131
|
53
|
20025951-8
|
TASIGNA de 150 mg; TABLETA / CÁPSULA; x 120
|
NOVARTIS PHARMAA.G.
|
$
7.227.308,56
|
|
132
|
55
|
19943740-1
|
PROGRAF de 5 mg; TABLETA / CÁPSULA; x 50
|
JANSSEN CILAG S.A.
|
$
1.098.248,91
|
|
133
|
55
|
19943740-2
|
PROGRAF de 5 mg; TABLETA / CÁPSULA; x 100
|
JANSSEN CILAG S.A.
|
$
2.196.497,84
|
|
134
|
55
|
19943741-1
|
PROGRAF de 1 mg; TABLETA / CÁPSULA; x 50
|
JANSSEN CILAG S.A.
|
$
219.649,78
|
|
135
|
55
|
19943741-2
|
PROGRAF de 1 mg; TABLETA / CÁPSULA; x 100
|
JANSSEN CILAG S.A.
|
$
439.299,57
|
|
136
|
55
|
20024899-1
|
TACROLIMUS de 1 mg; TABLETA / CÁPSULA; x 25
|
SANDOZ S.A.
|
$
109.824,89
|
|
137
|
55
|
20024899-2
|
TACROLIMUS de 1 mg; TABLETA / CÁPSULA; x 50
|
SANDOZ S.A.
|
$
219.649,78
|
|
138
|
55
|
20024899-3
|
TACROLIMUS de 1 mg; TABLETA / CÁPSULA; x 100
|
SANDOZ S.A.
|
$
439.299,57
|
|
139
|
55
|
20024899-4
|
TACROLIMUS de 1 mg; TABLETA / CÁPSULA; x 200
|
SANDOZ S.A.
|
$
878.599,13
|
|
140
|
55
|
20024901-1
|
TACROLIMUS de 5 mg; TABLETA / CÁPSULA; x 25
|
SANDOZ S.A.
|
$
549.124,46
|
|
141
|
55
|
20024901-2
|
TACROLIMUS de 5 mg; TABLETA / CÁPSULA; x 50
|
SANDOZ S.A.
|
$
1.098.248,91
|
|
142
|
55
|
20024901-3
|
TACROLIMUS de 5 mg; TABLETA / CÁPSULA; x 100
|
SANDOZ S.A.
|
$
2.196.497,84
|
|
143
|
55
|
20024901-4
|
TACROLIMUS de 5 mg; TABLETA / CÁPSULA; x 200
|
SANDOZ S.A.
|
$
4.392.995,67
|
|
144
|
60
|
19900426-1
|
REBIF de 44 mcg en 0,5 ml-88mcg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 1
|
MERCK S.A.
|
$
275.566,83
|
|
145
|
60
|
19900426-2
|
REBIF de 44 mcg en 0,5 ml-88mcg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 3
|
MERCK S.A.
|
$
826.700,50
|
|
146
|
60
|
19900426-3
|
REBIF de 44 mcg en 0,5 ml-88mcg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 12
|
MERCK S.A.
|
$
3.306.802,03
|
|
147
|
60
|
19900426-4
|
REBIF de 44 mcg en 0,5 ml-88mcg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 16
|
MERCK S.A.
|
$
4.409.069,37
|
|
148
|
60
|
20013593-1
|
REBIF de 132 mcg en 1,5 ml-88mcg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 4
|
MERCK S.A.
|
$
3.306.802,03
|
|
149
|
61
|
20041743-1
|
ORENCIA de 125 mg en 1 ml-125mcg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 4
|
BRISTOL MYERS SQUIBB DE COLOMBIA S.A.
|
$
2.225.999,87
|
|
150
|
61
|
20041743-2
|
ORENCIA de 125 mg en 1 ml-125mg/ml; SOLUCION/SUSPENSIÓN
INYECTABLE; x 4
|
BRISTOL MYERS SQUIBB DE COLOMBIA S.A.
|
$
2.225.999,87
|
|
151
|
62
|
19901547-1
|
ENBREL de 25 mg; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; x 4
|
LABORATORIOS WYETH INC.
|
$
1.341.147,61
|
|
152
|
62
|
19901547-2
|
ENBREL de 25 mg; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; x 4
|
LABORATORIOS WYETH INC.
|
$
1.341.147,61
|
|
153
|
62
|
19901547-3
|
ENBREL de 25 mg; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; x 4
|
LABORATORIOS WYETH INC.
|
$
1.341.147,61
|
|
154
|
62
|
19968208-1
|
ETANAR de 25 mg; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; x 1
|
LA SANTE
|
$
335.286,90
|
|
155
|
62
|
19968208-2
|
ETANAR de 25 mg; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; x 4
|
LA SANTE
|
$
1.341.147,61
|
|
156
|
62
|
19968208-3
|
ETANAR de 25 mg; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; x 4
|
LA SANTE
|
$
1.341.147,61
|
|
157
|
62
|
19968208-4
|
ETANAR de 25 mg; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; x 4
|
LA SANTE
|
$
1.341.147,61
|
|
158
|
62
|
19968208-5
|
ETANAR de 25 mg; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; x 4
|
LA SANTE
|
$
1.341.147,61
|
|
159
|
62
|
19968208-6
|
ETANAR de 25 mg; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; x 4
|
LA SANTE
|
$
1.341.147,61
|
|
160
|
62
|
19968208-7
|
ETANAR de 25 mg; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; x 4
|
LA SANTE
|
$
1.341.147,61
|
|
161
|
62
|
19968208-8
|
ETANAR de 25 mg; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; x 4
|
LA SANTE
|
$
1.341.147,61
|
|
162
|
62
|
19968208-9
|
ETANAR de 25 mg; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; x 1
|
LA SANTE
|
$
335.286,90
|
|
163
|
62
|
19978839-10
|
ENBREL de 25 mg; SOLUCION/SUSPENSIÓN INYECTABLE; x 8
|
PFIZER S.A.S.
|
$
2.682.295,23
|
|
164
|
62
|
19978839-11
|
ENBREL de 25 mg; SOLUCION/SUSPENSIÓN INYECTABLE; X 12
|
PFIZER S.A.S.
|
$
4.023.442,84
|
|
165
|
62
|
19978839-12
|
ENBREL de 25 mg; SOLUCION/SUSPENSIÓN INYECTABLE; x 24
|
PFIZER S.A.S.
|
$
8.046.885,68
|
|
166
|
62
|
19978839-4
|
ENBREL de 25 mg en 0,5 ml-50mg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 2
|
PFIZER S.A.S.
|
$
670.573,81
|
|
167
|
62
|
19978839-5
|
ENBREL de 25 mg en 0,5 ml-50mg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 4
|
PFIZER S.A.S.
|
$
1.341.147,61
|
|
168
|
62
|
19978839-6
|
ENBREL de 25 mg en 0,5 ml-50mg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 12
|
PFIZER S.A.S.
|
$
4.023.442,84
|
|
169
|
62
|
19978839-7
|
ENBREL de 25 mg en 0,5 ml-50mg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 4
|
PFIZER S.A.S.
|
$
1.341.147,61
|
|
170
|
62
|
19978841-1
|
ENBREL de 50 mg en 0,5 ml-100mg/ml-: SOLUCION/SUSPENSIÓN
INYECTABLE; x 2
|
PFIZER S.A.S.
|
$
1.341.147,61
|
|
171
|
62
|
19978841-13
|
ENBREL de 50 mg en 0,5 ml-100mg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 4
|
PFIZER S.A.S.
|
$
2.682.295,23
|
|
172
|
62
|
19978841-15
|
ENBREL de 50 mg en 0,5 ml-IOOmg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 8
|
PFIZER S.A.S.
|
$
5.364.590,45
|
|
173
|
62
|
19978841-16
|
ENBREL de 50 mg en 0,5 ml-100mg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 12
|
PFIZER S.A.S.
|
$
8.046.885,68
|
|
174
|
62
|
19978841-17
|
ENBREL de 50 mg en 0,5 ml-100mg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 24
|
PFIZER S.A.S.
|
$
16.093.771,35
|
|
175
|
62
|
19978841-2
|
ENBREL de 50 mg en 0,5 ml-100mg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 4
|
PFIZER S.A.S.
|
$
2.682.295,23
|
|
176
|
62
|
19978841-3
|
ENBREL de 50 mg en 0,5 ml-100mg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 12
|
PFIZER S.A.S.
|
$
8.046.885,68
|
|
177
|
62
|
19978841-7
|
ENBREL de 50 mg en 0,5 ml-100mg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 4
|
PFIZER S.A.S.
|
$
2.682.295,23
|
|
178
|
62
|
19978841-8
|
ENBREL de 50 mg en 0,5 ml-100mg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 4
|
PFIZER S.A.S.
|
$
2.682.295,23
|
|
179
|
62
|
19978841-9
|
ENBREL de 50 mg en 0,5 ml-IOOmg/ml; SOLUCION/SUSPENSIÓN
INYECTABLE; x 4
|
PFIZER S.A.S.
|
$
2.682.295,23
|
|
180
|
66
|
19976227-1
|
ORENCIA de 250 mg; POLVO LIOFILIZADO PARA RECONSTITUIR A
SOLUCION INYECTABLE; X 1
|
BRISTOL MYERS SQUIBB DE COLOMBIA S.A.
|
$
925.403,12
|
|
181
|
67
|
19977936-1
|
AVONEX de 30 mcg en 0,5 ml-60mcg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 1
|
STENDHAL COLOMBIA S.A.S.
|
$
563.529,19
|
|
182
|
67
|
19977936-2
|
AVONEX de 30 mcg en 0,5 ml-60mcg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 4
|
STENDHAL COLOMBIA S.A.S.
|
$
2.254.116,73
|
|
183
|
67
|
19977936-3
|
AVONEX de 30 mcg en 0,5 ml-60mcg/ml-; SOLUCION/SUSPENSIÓN
INYECTABLE; x 4
|
STENDHAL COLOMBIA S.A.S.
|
$
2.254.116,73
|
|
184
|
69
|
33103-1
|
ACTILYSE - 50 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 2
|
BOEHRINGER
|
$
2.680.595,72
|
|
185
|
69
|
33103-2
|
ACTILYSE - 50 mg - POLVO RECONSTITUIR A SOLUCION / SUSPENSION
INYECTABLE X 2
|
BOEHRINGER
|
$
2.680.595,72
|
|
186
|
74
|
19908644-1
|
CASODEX -150 mg - TABLETA / CAPSULA x 28
|
ASTRAZENECA
|
$
373.159,47
|
|
187
|
74
|
19908644-3
|
CASODEX -150 mg - TABLETA / CAPSULA x 28
|
ASTRAZENECA
|
$
373.159,47
|
|
188
|
74
|
19916203-1
|
LUTAMIDAL -150 mg - TABLETA / CAPSULA x 5
|
MONTEVERDE
|
$
66.635,62
|
|
189
|
74
|
19916203-10
|
LUTAMIDAL -150 mg - TABLETA / CAPSULA x 21
|
MONTEVERDE
|
$
279.869,60
|
|
190
|
74
|
19916203-11
|
LUTAMIDAL -150 mg - TABLETA / CAPSULA x 28
|
MONTEVERDE
|
$
373.159,47
|
|
191
|
74
|
19916203-12
|
LUTAMIDAL -150 mg - TABLETA / CAPSULA x 10
|
MONTEVERDE
|
$
133.271,23
|
|
192
|
74
|
19916203-13
|
LUTAMIDAL -150 mg - TABLETA / CAPSULA x 20
|
MONTEVERDE
|
$
266.542,48
|
|
193
|
74
|
19916203-14
|
LUTAMIDAL -150 mg - TABLETA / CAPSULA x 30
|
MONTEVERDE
|
$
399.813,71
|
|
194
|
74
|
19916203-15
|
LUTAMIDAL -150 mg - TABLETA / CAPSULA x 40
|
MONTEVERDE
|
$
533.084,95
|
|
195
|
74
|
19916203-16
|
LUTAMIDAL -150 mg - TABLETA / CAPSULA x 50
|
MONTEVERDE
|
$
666.356,18
|
|
196
|
74
|
19916203-17
|
LUTAMIDAL -150 mg - TABLETA / CAPSULA x 14
|
MONTEVERDE
|
$
186.579,73
|
|
197
|
74
|
19916203-19
|
LUTAMIDAL -150 mg - TABLETA / CAPSULA x 42
|
MONTEVERDE
|
$
559.739,19
|
|
198
|
74
|
19916203-2
|
LUTAMIDAL -150 mg - TABLETA / CAPSULA x 10
|
MONTEVERDE
|
$
133.271,23
|
|
199
|
74
|
19916203-20
|
LUTAMIDAL - 150 mg - TABLETA / CAPSULA x 56
|
MONTEVERDE
|
$
746.318,93
|
|
200
|
74
|
19916203-21
|
LUTAMIDAL - 150 mg - TABLETA / CAPSULA x 70
|
MONTEVERDE
|
$
932.898,66
|
|
201
|
74
|
19916203-22
|
LUTAMIDAL - 150 mg - TABLETA / CAPSULA x 7
|
MONTEVERDE
|
$
93.289,86
|
|
202
|
74
|
19916203-23
|
LUTAMIDAL -150 mg - TABLETA / CAPSULA x 10
|
MONTEVERDE
|
$
133.271,23
|
|
203
|
74
|
19916203-24
|
LUTAMIDAL -150 mg - TABLETA / CAPSULA x 14
|
MONTEVERDE
|
$
186.579,73
|
|
204
|
74
|
19916203-25
|
LUTAMIDAL -150 mg - TABLETA / CAPSULA x 20
|
MONTEVERDE
|
$
266.542,48
|
|
205
|
74
|
19916203-27
|
LUTAMIDAL - 150 mg - TABLETA / CAPSULA x 30
|
MONTEVERDE
|
$
399.813,71
|
|
206
|
74
|
19916203-28
|
LUTAMIDAL -150 mg - TABLETA / CAPSULA x 42
|
MONTEVERDE
|
$
559.739,19
|
|
207
|
74
|
19916203-29
|
LUTAMIDAL -150 mg - TABLETA / CAPSULA x 64
|
MONTEVERDE
|
$
852.935,92
|
|
208
|
74
|
19916203-3
|
LUTAMIDAL -150 mg - TABLETA / CAPSULA x 14
|
MONTEVERDE
|
$
186.579,73
|
|
209
|
74
|
19916203-4
|
LUTAMIDAL -150 mg - TABLETA / CAPSULA x 7
|
MONTEVERDE
|
$
93.289,86
|
|
210
|
74
|
19916203-5
|
LUTAMIDAL -150 mg - TABLETA / CAPSULA x 5
|
MONTEVERDE
|
$
66.635,62
|
|
211
|
74
|
19916203-6
|
LUTAMIDAL - 150 mg - TABLETA / CAPSULA x 10
|
MONTEVERDE
|
$
133.271,23
|
|
212
|
74
|
19916203-7
|
LUTAMIDAL - 150 mg - TABLETA / CAPSULA x 15
|
MONTEVERDE
|
$
199.906,85
|
|
213
|
74
|
19916203-8
|
LUTAMIDAL - 150 mg - TABLETA / CAPSULA x 7
|
MONTEVERDE
|
$
93.289,86
|
|
214
|
74
|
19916203-9
|
LUTAMIDAL - 150 mg - TABLETA / CAPSULA x 14
|
MONTEVERDE
|
$
186.579,73
|
|
215
|
74
|
201198-1
|
CASODEX - 50 mg - TABLETA / CAPSULA x 28
|
ASTRAZENECA
|
$
124.386,49
|
|
216
|
74
|
201198-3
|
CASODEX - 50 mg - TABLETA / CAPSULA x 28
|
ASTRAZENECA
|
$
124.386,49
|
|
217
|
74
|
2299.86-1
|
LUTAMIDAL - 50 mg - TABLETA / CAPSULA x 10
|
MONTEVERDE
|
$
44.423,74
|
|
218
|
74
|
229986-2
|
LUTAMIDAL - 50 mg - TABLETA / CAPSULA x 14
|
MONTEVERDE
|
$
62.193,24
|
|
219
|
74
|
229986-4
|
LUTAMIDAL - 50 mg - TABLETA / CAPSULA x 30
|
MONTEVERDE
|
$
133.271,23
|
|
220
|
74
|
229986-5
|
LUTAMIDAL - 50 mg - TABLETA / CAPSULA x 7
|
MONTEVERDE
|
$
31.096,62
|
|
221
|
76
|
19926495-1
|
CANCIDAS - 50 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 1
|
MERCK SHARP DOME
|
$
589.317,00
|
|
222
|
76
|
19926496-2
|
CANCIDAS - 70 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 1
|
MERCK SHARP DOME
|
$
825.043,81
|
|
223
|
77
|
19943209-1
|
BIOSPORIN - 50 mg - TABLETA / CAPSULA x 10
|
BIOTOSCANA
|
$
30.884,98
|
|
224
|
77
|
19943209-2
|
BIOSPORIN - 50 mg - TABLETA / CAPSULA x 50
|
BIOTOSCANA
|
$
154.424,89
|
|
225
|
77
|
19943209-3
|
BIOSPORIN - 50 mg - TABLETA / CAPSULA x 100
|
BIOTOSCANA
|
$
308.849,79
|
|
226
|
77
|
33037-1
|
SANDIMMUN -100 mg - TABLETA / CAPSULA x 50
|
NOVARTIS
|
$
308.849,79
|
|
227
|
77
|
33038-1
|
SANDIMMUN - 25 mg - TABLETA / CAPSULA x 50
|
NOVARTIS
|
$
77.212,45
|
|
228
|
77
|
51612-1
|
SANDIMMUN - 50 mg - TABLETA / CAPSULA x 50
|
NOVARTIS
|
$
154.424,89
|
|
229
|
78
|
19993896-1
|
PRADAXA - 75 mg - TABLETA / CAPSULA x 10
|
BOEHRINGER
|
$
23.902,71
|
|
230
|
78
|
19993896-2
|
PRADAXA - 75 mg - TABLETA / CAPSULA x 30
|
BOEHRINGER
|
$
71.708,14
|
|
231
|
78
|
19993897-1
|
PRADAXA -110 mg - TABLETA / CAPSULA x 10
|
BOEHRINGER
|
$
35.057,31
|
|
232
|
80
|
19964303-1
|
EXJADE -125 mg - TABLETA / CAPSULA x 28
|
NOVARTIS
|
$
459.025,17
|
|
233
|
80
|
19964303-2
|
EXJADE -125 mg - TABLETA / CAPSULA x 28
|
NOVARTIS
|
$
459.025,17
|
|
234
|
80
|
19964304-2
|
EXJADE - 250 mg - TABLETA / CAPSULA x 28
|
NOVARTIS
|
$
918.050,32
|
|
235
|
80
|
19964305-1
|
EXJADE - 500 mg - TABLETA / CAPSULA x 28
|
NOVARTIS
|
$
1.836.100,66
|
|
236
|
81
|
200666-1
|
PULMOZYME - 2,5 mg - 2,5 mi -1 mg/ml - SOLUCION /
SUSPENSION PARA INHALACION x 6
|
ROCHE
|
$
426.113,86
|
|
237
|
82
|
19945567-2
|
NEXIUM - 40 mg - POLVO RECONSTITUIR A SOLUCION / SUSPENSION
INYECTABLE x 10
|
ASTRAZENECA
|
$
167.084,43
|
|
238
|
82
|
19945567-3
|
NEXIUM - 40 mg - POLVO RECONSTITUIR A SOLUCION / SUSPENSION
INYECTABLE x 1
|
ASTRAZENECA
|
$
16.708,44
|
|
239
|
82
|
19945567-5
|
NEXIUM - 40 mg - POLVO RECONSTITUIR A SOLUCION / SUSPENSION
INYECTABLE x 10
|
ASTRAZENECA
|
$
167.084,43
|
|
240
|
82
|
19945567-6
|
NEXIUM - 40 mg - POLVO RECONSTITUIR A SOLUCION / SUSPENSION
INYECTABLE x 1
|
ASTRAZENECA
|
$
16.708,44
|
|
241
|
84
|
19903238-1
|
AROMASIN - 25 mg - TABLETA / CAPSULA x 15
|
PFIZER
|
$
145.073,12
|
|
242
|
84
|
19903238-11
|
AROMASIN - 25 mg - TABLETA / CAPSULA x 60
|
PFIZER
|
$
580.292,50
|
|
243
|
84
|
19903238-12
|
AROMASIN - 25 mg - TABLETA / CAPSULA x 90
|
PFIZER
|
$
870.438,74
|
|
244
|
84
|
19903238-13
|
AROMASIN - 25 mg - TABLETA / CAPSULA x 100
|
PFIZER
|
$
967.154,16
|
|
245
|
84
|
19903238-2
|
AROMASIN - 25 mg - TABLETA / CAPSULA x 30
|
PFIZER
|
$
290.146,25
|
|
246
|
84
|
19903238-3
|
AROMASIN - 25 mg - TABLETA / CAPSULA x 90
|
PFIZER
|
$
870.438,74
|
|
247
|
84
|
19903238-5
|
AROMASIN - 25 mg - TABLETA / CAPSULA x 10
|
PFIZER
|
$
96.715,42
|
|
248
|
84
|
19903238-6
|
AROMASIN - 25 mg - TABLETA / CAPSULA x 20
|
PFIZER
|
$
193.430,83
|
|
249
|
84
|
19903238-7
|
AROMASIN - 25 mg - TABLETA / CAPSULA x 50
|
PFIZER
|
$
483.577,08
|
|
250
|
84
|
20044695-1
|
HB ONCOFEME - 25 mg - TABLETA / CAPSULA x 30
|
HB HUMAN BIOSCIENCE
|
$
290.146,25
|
|
251
|
84
|
20047845-1
|
EXEMESTIN - 25 mg - TABLETA / CAPSULA x 30
|
WELFARE
|
$
290.146,25
|
|
252
|
87
|
19955642-2
|
FASLODEX - 250 mg - 5 mi - 50 mg/ml - SOLUCION / SUSPENSION
INYECTABLE x 1
|
ASTRAZENECA
|
$
975.088,29
|
|
253
|
87
|
19955642-3
|
FASLODEX - 250 mg - 5 mi - 50 mg/ml - SOLUCION / SUSPENSION
INYECTABLE x 2
|
ASTRAZENECA
|
$
1.950.176,57
|
|
254
|
88
|
35388-1
|
MAGNEVIST - 46900 mg -100 mi - 469 mg/ml -SOLUCION /
SUSPENSION INYECTABLE x 1
|
BAYER
|
$
425.721,79
|
|
255
|
88
|
35388-2
|
MAGNEVIST - 4690 mg -10 mi - 469 mg/ml -SOLUCION /
SUSPENSION INYECTABLE x 1
|
BAYER
|
$
42.572,17
|
|
256
|
88
|
35388-3
|
MAGNEVIST - 7035 mg -15 mi - 469 mg/ml -SOLUCION /
SUSPENSION INYECTABLE x 1
|
BAYER
|
$
63.858,26
|
|
257
|
88
|
35388-4
|
MAGNEVIST - 14070 mg - 30 mi - 469 mg/ml -SOLUCION /
SUSPENSION INYECTABLE x 1
|
BAYER
|
$
127.716,54
|
|
258
|
88
|
35388-5
|
MAGNEVIST - 46900 mg -100 mi - 469 mg/ml -SOLUCION /
SUSPENSION INYECTABLE x 1
|
BAYER
|
$
425.722,57
|
|
259
|
94
|
19910693-1
|
NOVORAPID - 300 Ul - 3 mi -100 Ul/ml - SOLUCION /
SUSPENSION INYECTABLE x 5
|
NOVO NORDISK
|
$
98.533,57
|
|
260
|
94
|
19910693-2
|
NOVORAPID - 300 Ul - 3 mi -100 Ul/ml - SOLUCION /
SUSPENSION INYECTABLE x 1
|
NOVO NORDISK
|
$
19.706,71
|
|
261
|
94
|
19910693-3
|
NOVORAPID - 300 Ul - 3 mi -100 Ul/ml - SOLUCION /
SUSPENSION INYECTABLE x 1
|
NOVO NORDISK
|
$
19.706,71
|
|
262
|
94
|
19910693-4
|
NOVORAPID - 300 Ul - 3 mi -100 Ul/ml - SOLUCION /
SUSPENSION INYECTABLE x 1
|
NOVO NORDISK
|
$
19.706,71
|
|
263
|
94
|
19910693-5
|
NOVORAPID - 300 Ul - 3 mi -100 Ul/ml - SOLUCION /
SUSPENSION INYECTABLE x 1
|
NOVO NORDISK
|
$
19.706,71
|
|
264
|
94
|
19910693-6
|
NOVORAPID - 300 Ul - 3 mi -100 Ul/ml - SOLUCION /
SUSPENSION INYECTABLE x 5
|
NOVO NORDISK
|
$
98.533,57
|
|
265
|
94
|
19910693-7
|
NOVORAPID - 300 Ul - 3 mi -100 Ul/ml - SOLUCION /
SUSPENSION INYECTABLE X 10
|
NOVO NORDISK
|
$
197.067,14
|
|
266
|
95
|
19972118-1
|
LEVEMIR - 42,6 mg - 3 mi -14,2 mg/ml - SOLUCION /
SUSPENSION INYECTABLE x 1
|
NOVO NORDISK
|
$
31.515,11
|
|
267
|
95
|
19972118-2
|
LEVEMIR - 42,6 mg - 3 mi -14,2 mg/ml - SOLUCION /
SUSPENSION INYECTABLE x 5
|
NOVO NORDISK
|
$
157.575,57
|
|
268
|
95
|
19972118-3
|
LEVEMIR - 42,6 mg - 3 mi -14,2 mg/ml - SOLUCION /
SUSPENSION INYECTABLE x 10
|
NOVO NORDISK
|
$
315.151,15
|
|
269
|
95
|
19972118-4
|
LEVEMIR - 42,6 mg - 3 mi -14,2 mg/ml - SOLUCION /
SUSPENSION INYECTABLE x 1
|
NOVO NORDISK
|
$
31.515,11
|
|
270
|
95
|
19972118-5
|
LEVEMIR - 42,6 mg - 3 mi -14,2 mg/ml - SOLUCION /
SUSPENSION INYECTABLE x 5
|
NOVO NORDISK
|
$
157.575,57
|
|
271
|
95
|
19972118-6
|
LEVEMIR - 42,6 mg - 3 mi -14,2 mg/ml - SOLUCION /
SUSPENSION INYECTABLE x 10
|
NOVO NORDISK
|
$
315.151,15
|
|
272
|
95
|
19972118-7
|
LEVEMIR - 42,6 mg - 3 mi -14,2 mg/ml - SOLUCION /
SUSPENSION INYECTABLE x 1
|
NOVO NORDISK
|
$
31.515,11
|
|
273
|
95
|
19972118-8
|
LEVEMIR - 42,6 mg - 3 mi -14,2 mg/ml - SOLUCION / SUSPENSION
INYECTABLE x 5
|
NOVO NORDISK
|
$
157.575,57
|
|
274
|
95
|
19972118-9
|
LEVEMIR - 42,6 mg - 3 ml - 14,2 mg/ml - SOLUCION /
SUSPENSION INYECTABLE x 10
|
NOVO NORDISK
|
$
315.151,15
|
|
275
|
96
|
19914262-2
|
LANTUS - 1000 Ul -10 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 1
|
SANOFI AVENTIS
|
$
99.810,54
|
|
276
|
96
|
19914262-4
|
LANTUS - 1000 Ul -10 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 1
|
SANOFI AVENTIS
|
$
99.810,54
|
|
277
|
96
|
19914262-5
|
LANTUS - 1000 Ul -10 ml - 100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 2
|
SANOFI AVENTIS
|
$
199.621,07
|
|
278
|
96
|
19914262-6
|
LANTUS - 1000 Ul -10 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 5
|
SANOFI AVENTIS
|
$
499.052,69
|
|
279
|
96
|
19914262-7
|
LANTUS - 1000 Ul -10 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 10
|
SANOFI AVENTIS
|
$
998.105,38
|
|
280
|
96
|
19914312-10
|
LANTUS - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 1
|
SANOFI AVENTIS
|
$
29.943,16
|
|
281
|
96
|
19914312-11
|
LANTUS - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 5
|
SANOFI AVENTIS
|
$
149.715,80
|
|
282
|
96
|
19914312-12
|
LANTUS - 300 Ul-3 mi-100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 1
|
SANOFI AVENTIS
|
$
29.943,16
|
|
283
|
96
|
19914312-13
|
LANTUS - 300 Ul - 3 mi -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 3
|
SANOFI AVENTIS
|
$
89.829,49
|
|
284
|
96
|
19914312-14
|
LANTUS - 300 Ul - 3 mi -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 4
|
SANOFI AVENTIS
|
$
119.772,65
|
|
285
|
96
|
19914312-15
|
LANTUS - 300 Ul - 3 mi -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 5
|
SANOFI AVENTIS
|
$
149.715,80
|
|
286
|
96
|
19914312-16
|
LANTUS - 300 Ul - 3 mi -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 6
|
SANOFI AVENTIS
|
$
179.658,97
|
|
287
|
96
|
19914312-17
|
LANTUS - 300 Ul - 3 mi -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 8
|
SANOFI AVENTIS
|
$
239.545,29
|
|
288
|
96
|
19914312-18
|
LANTUS - 300 Ul - 3 mi -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 9
|
SANOFI AVENTIS
|
$
269.488,45
|
|
289
|
96
|
19914312-19
|
LANTUS - 300 Ul - 3 mi -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 10
|
SANOFI AVENTIS
|
$
299.431,62
|
|
290
|
96
|
19914312-2
|
LANTUS - 300 Ul - 3 mi -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 1
|
SANOFI AVENTIS
|
$
29.943,16
|
|
291
|
96
|
19914312-20
|
LANTUS - 300 Ul - 3 mi -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 1
|
SANOFI AVENTIS
|
$
29.943,16
|
|
292
|
96
|
19914312-21
|
LANTUS - 300 Ul - 3 mi -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 5
|
SANOFI AVENTIS
|
$
149.715,80
|
|
293
|
96
|
19914312-3
|
LANTUS - 300 Ul - 3 mi -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 5
|
SANOFI AVENTIS
|
$
149.715,80
|
|
294
|
96
|
19914312-4
|
LANTUS - 300 Ul - 3 mi -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 1
|
SANOFI AVENTIS
|
$
29.943,16
|
|
295
|
96
|
19914312-5
|
LANTUS - 300 Ul - 3 mi -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 5
|
SANOFI AVENTIS
|
$
149.715,80
|
|
296
|
96
|
19914312-6
|
LANTUS - 300 Ul - 3 ml - 100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 1
|
SANOFI AVENTIS
|
$
29.943,16
|
|
297
|
96
|
19914312-7
|
LANTUS - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 5
|
SANOFI AVENTIS
|
$
149.715,80
|
|
298
|
96
|
19914312-8
|
LANTUS - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 10
|
SANOFI AVENTIS
|
$
299.431,62
|
|
299
|
96
|
19914312-9
|
LANTUS - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 4
|
SANOFI AVENTIS
|
$
119.772,65
|
|
300
|
97
|
19950479-1
|
APIDRA - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 1
|
SANOFI AVENTIS
|
$
17.301,55
|
|
301
|
97
|
19950479-10
|
APIDRA - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 10
|
SANOFI AVENTIS
|
$
173.015,45
|
|
302
|
97
|
19950479-11
|
APIDRA - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 1
|
SANOFI AVENTIS
|
$
17.301,55
|
|
303
|
97
|
19950479-12
|
APIDRA - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 3
|
SANOFI AVENTIS
|
$
51.904,63
|
|
304
|
97
|
19950479-13
|
APIDRA - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 4
|
SANOFI AVENTIS
|
$
69.206,18
|
|
305
|
97
|
19950479-14
|
APIDRA - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 5
|
SANOFI AVENTIS
|
$
86.507,73
|
|
306
|
97
|
19950479-15
|
APIDRA - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 6
|
SANOFI AVENTIS
|
$
103.809,27
|
|
307
|
97
|
19950479-16
|
APIDRA - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 8
|
SANOFI AVENTIS
|
$
138.412,36
|
|
308
|
97
|
19950479-17
|
APIDRA - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 9
|
SANOFI AVENTIS
|
$
155.713,91
|
|
309
|
97
|
19950479-18
|
APIDRA - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 10
|
SANOFI AVENTIS
|
$
173.015,45
|
|
310
|
97
|
19950479-19
|
APIDRA - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 1
|
SANOFI AVENTIS
|
$
17.301,55
|
|
311
|
97
|
19950479-2
|
APIDRA - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 5
|
SANOFI AVENTIS
|
$
86.507,73
|
|
312
|
97
|
19950479-20
|
APIDRA - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 3
|
SANOFI AVENTIS
|
$
86.507,73
|
|
313
|
97
|
19950479-3
|
APIDRA - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 1
|
SANOFI AVENTIS
|
$
17.301,55
|
|
314
|
97
|
19950479-4
|
APIDRA - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 3
|
SANOFI AVENTIS
|
$
51.904,63
|
|
315
|
97
|
19950479-5
|
APIDRA - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 4
|
SANOFI AVENTIS
|
$
69.206,18
|
|
316
|
97
|
19950479-6
|
APIDRA - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 5
|
SANOFI AVENTIS
|
$
86.507,73
|
|
317
|
97
|
19950479-7
|
APIDRA - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 6
|
SANOFI AVENTIS
|
$
103.809,27
|
|
318
|
97
|
19950479-8
|
APIDRA - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 8
|
SANOFI AVENTIS
|
$
138.412,36
|
|
319
|
97
|
19950479-9
|
APIDRA - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 9
|
SANOFI AVENTIS
|
$
155.713,91
|
|
320
|
98
|
224030-1
|
HUMALOG - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 2
|
ELI LILLY
|
$
34.582,07
|
|
321
|
98
|
224030-2
|
HUMALOG -1000 Ul -10 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 1
|
ELI LILLY
|
$
57.636,77
|
|
322
|
98
|
224030-3
|
HUMALOG -150 Ul -1,5 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 5
|
ELI LILLY
|
$
43.227,58
|
|
323
|
98
|
224030-4
|
HUMALOG - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 5
|
ELI LILLY
|
$
86.455,16
|
|
324
|
98
|
224030-5
|
HUMALOG - 300 Ul - 3 ml -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 5
|
ELI LILLY
|
$
86.455,16
|
|
325
|
98
|
224030-6
|
HUMALOG - 300 Ul - 3 mi -100 Ül/ml - SOLUCION / SUSPENSION
INYECTABLE x 1
|
ELI LILLY
|
$
17.291,03
|
|
326
|
98
|
224030-7
|
HUMALOG - 300 Ul - 3 mi -100 Ul/ml - SOLUCION / SUSPENSION
INYECTABLE x 2
|
ELI LILLY
|
$
34.582,07
|
|
327
|
101
|
19963298-1
|
INFLAXEN - 20 mg - TABLETA / CAPSULA x 10
|
PROCAPS
|
$
54.730,34
|
|
328
|
101
|
19963298-2
|
INFLAXEN - 20 mg - TABLETA / CAPSULA x 30
|
PROCAPS
|
$
164.191,02
|
|
329
|
101
|
19963298-3
|
INFLAXEN - 20 mg - TABLETA / CAPSULA x 60
|
PROCAPS
|
$
328.382,04
|
|
330
|
101
|
19963298-4
|
INFLAXEN - 20 mg - TABLETA / CAPSULA x 200
|
PROCAPS
|
$
1.094.606,79
|
|
331
|
101
|
19963299-1
|
INFLAXEN -100 mg - TABLETA / CAPSULA x 3
|
PROCAPS
|
$
82.095,51
|
|
332
|
101
|
19963299-2
|
INFLAXEN -100 mg - TABLETA / CAPSULA x 30
|
PROCAPS
|
$
820.955,10
|
|
333
|
101
|
19963299-3
|
INFLAXEN -100 mg - TABLETA / CAPSULA x 1
|
PROCAPS
|
$
27.365,17
|
|
334
|
101
|
230658-1
|
ARAVA - 20 mg - TABLETA / CAPSULA x 30
|
SANOFIAVENTIS
|
$
164.191,02
|
|
335
|
101
|
230660-1
|
ARAVA -100 mg - TABLETA / CAPSULA x 3
|
SANOFI AVENTIS
|
$
82.095,51
|
|
336
|
102
|
19956218-1
|
ELIGARD - 22,5 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 1
|
TOLMAR
|
$
1.093.422,17
|
|
337
|
102
|
20018782-1
|
LUPRON DEPOT - 30 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 1
|
ABBOTT -ABBVIE
|
$
1.457.896,23
|
|
338
|
102
|
20032905-1
|
ELIGARD - 45 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 1
|
TOLMAR
|
$
2.186.844,34
|
|
339
|
103
|
19936411-1
|
KEPPRA -1000 mg - TABLETA / CAPSULA x 30
|
GLAXOSMITHKLI NE
|
$
82.944,03
|
|
340
|
103
|
19936411-3
|
KEPPRA -1000 mg - TABLETA / CAPSULA x 20
|
GLAXOSMITHKLI NE
|
$
55.296,01
|
|
341
|
103
|
19936412-1
|
KEPPRA - 500 mg - TABLETA / CAPSULA x 20
|
GLAXOSMITHKLI NE
|
$
27.648,01
|
|
342
|
103
|
19936412-2
|
KEPPRA - 500 mg - TABLETA / CAPSULA x 30
|
GLAXOSMITHKLI NE
|
$
41.472,01
|
|
343
|
103
|
19936412-3
|
KEPPRA - 500 mg - TABLETA / CAPSULA x 60
|
GLAXOSMITHKLI NE
|
$
82.944,03
|
|
344
|
104
|
19929840-1
|
DAXIM -12,5 mg - 5 ml - 2,5 mg/ml - SOLUCION / SUSPENSION
INYECTABLE x 1
|
ABBVIE S.A.S.
|
$
1.737.545,48
|
|
345
|
107
|
19907394-1
|
ZYVOXID - 200 mg -100 ml - 2 mg/ml - SOLUCION / SUSPENSION
INYECTABLE x 1
|
PFIZER
|
$
51.147,04
|
|
346
|
107
|
19907394-10
|
ZYVOXID - 400 mg - 200 ml - 2 mg/ml - SOLUCION / SUSPENSION
INYECTABLE x 1
|
PFIZER
|
$
102.294,07
|
|
347
|
107
|
19907394-2
|
ZYVOXID - 400 mg - 200 ml - 2 mg/ml - SOLUCION / SUSPENSION
INYECTABLE x 1
|
PFIZER
|
$
102.294,07
|
|
348
|
107
|
19907394-4
|
ZYVOXID - 200 mg -100 ml - 2 mg/ml - SOLUCION / SUSPENSION
INYECTABLE x 1
|
PFIZER
|
$
51.147,04
|
|
349
|
107
|
19907394-5
|
ZYVOXID - 400 mg - 200 ml - 2 mg/ml - SOLUCION / SUSPENSION
INYECTABLE x 1
|
PFIZER
|
$
102.294,07
|
|
350
|
107
|
19907394-9
|
ZYVOXID - 200 mg -100 ml - 2 mg/nil - SOLUCION / SUSPENSION
INYECTABLE x 1
|
PFIZER
|
$
51.147,04
|
|
351
|
109
|
20010367-1
|
MEROBAC -1000 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 1
|
PROCAPS
|
$
58.247,33
|
|
352
|
109
|
20010367-10
|
MEROBAC -1000 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 25
|
PROCAPS
|
$
1.456.183,21
|
|
353
|
109
|
20010367-11
|
MEROBAC - 1000 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 50
|
PROCAPS
|
$
2.912.366,42
|
|
354
|
109
|
20010367-12
|
MEROBAC - 1000 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 100
|
PROCAPS
|
$
5.824.732,84
|
|
355
|
109
|
20010367-2
|
MEROBAC -1000 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 5
|
PROCAPS
|
$
291.236,64
|
|
356
|
109
|
20010367-3
|
MEROBAC -1000 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 10
|
PROCAPS
|
$
582.473,29
|
|
357
|
109
|
20010367-4
|
MEROBAC - 1000 mg - POLVO RECONSTITUIRA SOLUCION /
SUSPENSION INYECTABLE x 25
|
PROCAPS
|
$
1.456.183,21
|
|
358
|
109
|
20010367-5
|
MEROBAC -1000 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 50
|
PROCAPS
|
$
2.912.366,42
|
|
359
|
109
|
20010367-6
|
MEROBAC -1000 mg - POLVO RECONSTITUIRA SOLUCION /
SUSPENSION INYECTABLE x 100
|
PROCAPS
|
$
5.824.732,84
|
|
360
|
109
|
20010367-7
|
MEROBAC -1000 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 1
|
PROCAPS
|
$
58.247,33
|
|
361
|
109
|
20010367-8
|
MEROBAC -1000 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 5
|
PROCAPS
|
$
291.236,64
|
|
362
|
109
|
20010367-9
|
MEROBAC - 1000 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 10
|
PROCAPS
|
$
582.473,29
|
|
363
|
109
|
20010478-1
|
MEROBAC - 500 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 1
|
PROCAPS
|
$
29.123,66
|
|
364
|
109
|
20010478-10
|
MEROBAC - 500 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 25
|
PROCAPS
|
$
728.091,60
|
|
365
|
109
|
20010478-11
|
MEROBAC - 500 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 50
|
PROCAPS
|
$
1.456.183,21
|
|
366
|
109
|
20010478-12
|
MEROBAC - 500 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 100
|
PROCAPS
|
$
2.912.366,42
|
|
367
|
109
|
20010478-2
|
MEROBAC - 500 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 5
|
PROCAPS
|
$
145.618,32
|
|
368
|
109
|
20010478-3
|
MEROBAC - 500 mg - POLVO RECONSTITUIRA SOLUCION /
SUSPENSION INYECTABLE x 10
|
PROCAPS
|
$
291.236,64
|
|
369
|
109
|
20010478-4
|
MEROBAC - 500 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 25
|
PROCAPS
|
$
728.091,60
|
|
370
|
109
|
20010478-5
|
MEROBAC - 500 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 50
|
PROCAPS
|
$
1.456.183,21
|
|
371
|
109
|
20010478-6
|
MEROBAC - 500 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 100
|
PROCAPS
|
$
2.912.366,42
|
|
372
|
109
|
20010478-7
|
MEROBAC - 500 ma - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 1
|
PROCAPS
|
29.123.66
|
|
373
|
109
|
20010478-8
|
MEROBAC - 500 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 5
|
PROCAPS
|
$
145.618,32
|
|
374
|
109
|
20010478-9
|
MEROBAC - 500 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 10
|
PROCAPS
|
$
291.236,64
|
|
375
|
109
|
201199-2
|
MERONEM -1000 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 10
|
ASTRAZENECA
|
$
582.473,29
|
|
376
|
109
|
201199-3
|
MERONEM - 1000 mg - POLVO RECONSTITUIRA SOLUCION /
SUSPENSION INYECTABLE x 10
|
ASTRAZENECA
|
$
582.473,29
|
|
377
|
109
|
201200-1
|
MERONEM - 500 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 10
|
ASTRAZENECA
|
$
291.236,64
|
|
378
|
109
|
201200-3
|
MERONEM - 500 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 10
|
ASTRAZENECA
|
$
291.236,64
|
|
379
|
110
|
19927243-1
|
DEPO-MEDROL - 40 mg -1 mi - 40,00 mg/ml -SOLUCION /
SUSPENSION INYECTABLE x 1
|
PFIZER
|
$
5.190,13
|
|
380
|
110
|
53896-1
|
SOLU- MEDROL - 40 mg -1,2 mi - 33,33 mg/ml -POLVO
RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 1
|
PFIZER
|
$
5.190,13
|
|
381
|
110
|
53896-2
|
SOLU- MEDROL - 40 mg -1,2 mi - 33,33 mg/ml -POLVO
RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 5
|
PFIZER
|
$
25.950,67
|
|
382
|
110
|
53896-3
|
SOLU- MEDROL - 40 mg -1,2 ml - 33,33 mg/ml -POLVO
RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 10
|
PFIZER
|
$
51.901,35
|
|
383
|
110
|
53896-4
|
SOLU- MEDROL - 40 mg -1,2 ml - 33,33 mg/ml -POLVO
RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE X 25
|
PFIZER
|
$
129.753,36
|
|
384
|
111
|
19934076-1
|
MYFORTIC - 360 mg - TABLETA / CAPSULA x 120
|
NOVARTIS
|
$
505.842,14
|
|
385
|
111
|
19934077-1
|
MYFORTIC - 180 mg - TABLETA / CAPSULA x 120
|
NOVARTIS
|
$
252.921,07
|
|
386
|
111
|
204751-1
|
CELLCEPT - 250 mg - TABLETA / CAPSULA x 100
|
ROCHE
|
$
292.732,71
|
|
387
|
111
|
204751-2
|
CELLCEPT - 250 mg - TABLETA / CAPSULA x 100
|
ROCHE
|
$
292.732,71
|
|
388
|
111
|
216049-3
|
CELLCEPT - 500 mg - TABLETA / CAPSULA x 50
|
ROCHE
|
$
292.732,71
|
|
389
|
112
|
228254-1
|
SANDOSTATIN LAR - 20 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 1
|
NOVARTIS
|
$
2.569.054,95
|
|
390
|
112
|
228256-2
|
SANDOSTATIN LAR - 30 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE k 1
|
NOVARTIS
|
$
3.853.582,42
|
|
391
|
113
|
19928405-2
|
OCTRIDE - 0,1 mg -1 ml - 0,1 mg/ml - SOLUCION / SUSPENSION
INYECTABLE x 1
|
CHALVER
|
$
15.969,28
|
|
392
|
113
|
20007947-1
|
SANDOSTATIN - 0,1 mg -1 ml - 0,1 mg/ml -SOLUCION /
SUSPENSION INYECTABLE x 1 -NOVARTIS
|
NOVARTIS
|
$
15.969,28
|
|
393
|
113
|
20007947-2
|
SANDOSTATIN - 0,1 mg -1 ml - 0,1 mg/ml -SOLUCION /
SUSf>ENSION INYECTABLE x 5 -NOVARTIS
|
NOVARTIS
|
$
79.846,39
|
|
394
|
115
|
20015270-1
|
MIRAPEX ER -1,5 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 10 -
|
BOEHRINGER
|
$
39.026,68
|
|
395
|
115
|
20015270-2
|
MIRAPEX ER -1,5 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 30
|
BOEHRINGER
|
$
117.080,02
|
|
396
|
115
|
20015270-3
|
MIRAPEX ER -1,5 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 60
|
BOEHRINGER
|
$
234.160,04
|
|
397
|
115
|
20015270-4
|
MIRAPEX ER -1,5 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 100
|
BOEHRINGER
|
$
390.266,73
|
|
398
|
115
|
20015271-1
|
MIRAPEX ER - 0,75 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 30
|
BOEHRINGER
|
$
58.540,01
|
|
399
|
115
|
20015271-2
|
MIRAPEX ER - 0,75 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 60
|
BOEHRINGER
|
$
117.080,02
|
|
400
|
115
|
20015271-3
|
MIRAPEX ER - 0,75 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 100
|
BOEHRINGER
|
$
195.133,37
|
|
401
|
115
|
20015271-4
|
MIRAPEX ER - 0,75 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 10
|
BOEHRINGER
|
$
19.513,34
|
|
402
|
115
|
20015272-1
|
MIRAPEX ER - 0,375 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 30
|
BOEHRINGER
|
$
29.270,01
|
|
403
|
115
|
20015272-2
|
MIRAPEX ER - 0,375 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 60
|
BOEHRINGER
|
$
58.540,01
|
|
404
|
115
|
20015272-3
|
MIRAPEX ER - 0,375 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 100
|
BOEHRINGER
|
$
97.566,68
|
|
405
|
115
|
20015272-5
|
MIRAPEX ER - 0,375 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 10
|
BOEHRINGER
|
$
9.756,67
|
|
406
|
115
|
20015273-1
|
MIRAPEX ER - 3 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 30
|
BOEHRINGER
|
$
234.160,04
|
|
407
|
115
|
20015273-2
|
MIRAPEX ER - 3 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 60
|
BOEHRINGER
|
$
468.320,08
|
|
408
|
115
|
20015273-3
|
MIRAPEX ER - 3 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 100
|
BOEHRINGER
|
$
780.533,46
|
|
409
|
115
|
20015273-4
|
MIRAPEX ER - 3 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 10
|
BOEHRINGER
|
$
78.053,34
|
|
410
|
115
|
20015274-1
|
MIRAPEX ER - 4,5 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 10
|
BOEHRINGER
|
$
117.080,02
|
|
411
|
115
|
20015274-2
|
MIRAPEX ER - 4,5 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 30
|
BOEHRINGER
|
$
351.240,07
|
|
412
|
115
|
20015274-3
|
MIRAPEX ER - 4.5 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 60
|
BOEHRINGER
|
$
702.480,12
|
|
413
|
115
|
20015274-4
|
MIRAPEX ER - 4.5 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 100
|
BOEHRINGER
|
$
1.170.800,21
|
|
414
|
116
|
19953202-15
|
LYRICA - 75 mg - TABLETA / CAPSULA x 100
|
PFIZER
|
$
169.161,40
|
|
415
|
116
|
19953202-16
|
LYRICA - 75 mg - TABLETA / CAPSULA x 200
|
PFIZER
|
$
338.322,81
|
|
416
|
116
|
19953202-19
|
LYRICA - 75 mg - TABLETA / CAPSULA x 14
|
PFIZER
|
$
23.682,60
|
|
417
|
116
|
19953202-2
|
LYRICA - 75 mg - TABLETA / CAPSULA x 28
|
PFIZER
|
$
47.365,20
|
|
418
|
116
|
19953202-3
|
LYRICA - 75 mg - TABLETA / CAPSULA x 6
|
PFIZER
|
$
10.149,69
|
|
419
|
116
|
19953202-4
|
LYRICA - 75 mg - TABLETA / CAPSULA x 7
|
PFIZER
|
$
11.841,29
|
|
420
|
116
|
19953202-5
|
LYRICA - 75 mg - TABLETA / CAPSULA x 10
|
PFIZER
|
$
16.916,14
|
|
421
|
116
|
19953202-6
|
LYRICA - 75 mg - TABLETA / CAPSULA x 20
|
PFIZER
|
$
33.832,28
|
|
422
|
116
|
19953202-7
|
LYRICA - 75 mg - TABLETA / CAPSULA x 30
|
PFIZER
|
$
50.748,43
|
|
423
|
116
|
19953202-8
|
LYRICA - 75 mg - TABLETA / CAPSULA x 60
|
PFIZER
|
$
101.496,84
|
|
424
|
116
|
19953203-3
|
LYRICA - 300 mg - TABLETA / CAPSULA x 6
|
PFIZER
|
$
40.598,74
|
|
425
|
116
|
19953203-4
|
LYRICA - 300 mg - TABLETA / CAPSULA x 7
|
PFIZER
|
$
47.365,20
|
|
426
|
116
|
19953203-5
|
LYRICA - 300 mg - TABLETA / CAPSULA x 10
|
PFIZER
|
$
67.664,56
|
|
427
|
116
|
19953203-6
|
LYRICA - 300 mg - TABLETA / CAPSULA x 20
|
PFIZER
|
$
135.329,13
|
|
428
|
116
|
19953203-7
|
LYRICA - 300 mg - TABLETA / CAPSULA x 30
|
PFIZER
|
$
202.993,68
|
|
429
|
116
|
19953203-8
|
LYRICA - 300 mg - TABLETA / CAPSULA x 60
|
PFIZER
|
$
405.987,37
|
|
430
|
116
|
19953204-1
|
LYRICA -150 mg - TABLETA / CAPSULA x 14
|
PFIZER
|
$
47.365,20
|
|
431
|
116
|
19953204-18
|
LYRICA -150 mg - TABLETA / CAPSULA x 100
|
PFIZER
|
$
338.322,81
|
|
432
|
116
|
19953204-19
|
LYRICA -150 mg - TABLETA / CAPSULA x 200
|
PFIZER
|
$
676.645,62
|
|
433
|
116
|
19953204-3
|
LYRICA -150 mg - TABLETA / CAPSULA x 6
|
PFIZER
|
$
20.299,37
|
|
434
|
116
|
19953204-4
|
LYRICA -150 mg - TABLETA / CAPSULA x 7
|
PFIZER
|
$
23.682,60
|
|
435
|
116
|
19953204-5
|
LYRICA -150 mg - TABLETA / CAPSULA x 10
|
PFIZER
|
$
33.832,28
|
|
436
|
116
|
19953204-6
|
LYRICA -150 mg - TABLETA / CAPSULA x 20
|
PFIZER
|
$
67.664,56
|
|
437
|
116
|
19953204-7
|
LYRICA -150 mg - TABLETA / CAPSULA x 28
|
PFIZER
|
$
94.730,39
|
|
438
|
116
|
19953204-8
|
LYRICA -150 mg - TABLETA / CAPSULA x 30
|
PFIZER
|
$
101.496,84
|
|
439
|
116
|
19953204-9
|
LYRICA -150 mg - TABLETA / CAPSULA x 60
|
PFIZER
|
$
202.993,68
|
|
440
|
116
|
20008675-1
|
ALONO - 75 mg - TABLETA / CAPSULA x 28
|
PFIZER
|
$
47.365,20
|
|
441
|
116
|
20008675-17
|
ALONO - 75 mg - TABLETA / CAPSULA x 100
|
PFIZER
|
$
169.161,40
|
|
442
|
116
|
20008675-18
|
ALONO - 75 mg - TABLETA / CAPSULA x 200
|
PFIZER
|
$
338.322,81
|
|
443
|
116
|
20008675-3
|
ALONO - 75 mg - TABLETA / CAPSULA x 30
|
PFIZER
|
$
50.748,43
|
|
444
|
116
|
20008675-4
|
ALONO - 75 mg - TABLETA / CAPSULA x 6
|
PFIZER
|
$
10.149,69
|
|
445
|
116
|
20008675-5
|
ALONO - 75 mg - TABLETA / CAPSULA x 7
|
PFIZER
|
$
11.841,29
|
|
446
|
116
|
20008675-6
|
ALONO - 75 mg - TABLETA / CAPSULA x 10
|
PFIZER
|
$
16.916,14
|
|
447
|
116
|
20008675-7
|
ALONO - 75 mg - TABLETA / CAPSULA x 14
|
PFIZER
|
$
23.682,60
|
|
448
|
116
|
20008675-8
|
ALONO - 75 mg - TABLETA / CAPSULA x 20
|
PFIZER
|
$
33.832,28
|
|
449
|
116
|
20008675-9
|
ALONO - 75 mg - TABLETA / CAPSULA x 60
|
PFIZER
|
$
101.496,84
|
|
450
|
116
|
20028912-1
|
ALONO - 25 mg - TABLETA / CAPSULA x 6
|
PFIZER
|
$
3.383,23
|
|
451
|
116
|
20028912-14
|
ALONO - 25 mg - TABLETA / CAPSULA x 100
|
PFIZER
|
$
56.387,13
|
|
452
|
116
|
20028912-15
|
ALONO - 25 mg - TABLETA / CAPSULA x 200
|
PFIZER
|
$
112.774,27
|
|
453
|
116
|
20028912-2
|
ALONO - 25 mg - TABLETA / CAPSULA x 7
|
PFIZER
|
$
3.947,09
|
|
454
|
116
|
20028912-3
|
ALONO - 25 mg - TABLETA / CAPSULA x 14
|
PFIZER
|
$
7.894,20
|
|
455
|
116
|
20028912-4
|
ALONO - 25 mg - TABLETA / CAPSULA x 28
|
PFIZER
|
$
15.788,40
|
|
456
|
116
|
20028912-5
|
ALONO - 25 mg - TABLETA / CAPSULA x 30
|
PFIZER
|
$
16.916,14
|
|
457
|
116
|
20028912-6
|
ALONO - 25 mg - TABLETA / CAPSULA x 60
|
PFIZER
|
$
33.832,28
|
|
458
|
116
|
20028918-1
|
LYRICA - 25 mg - TABLETA / CAPSULA x 6
|
PFIZER
|
$
3.383,23
|
|
459
|
116
|
20028918-13
|
LYRICA - 25 mg - TABLETA / CAPSULA x 100
|
PFIZER
|
$
56.387,13
|
|
460
|
116
|
20028918-14
|
LYRICA - 25 mg - TABLETA / CAPSULA x 200
|
PFIZER
|
$
112.774,27
|
|
461
|
116
|
20028918-2
|
LYRICA - 25 mg - TABLETA / CAPSULA x 7
|
PFIZER
|
$
3.947,09
|
|
462
|
116
|
20028918-3
|
LYRICA - 25 mg - TABLETA / CAPSULA x 14
|
PFIZER
|
$
7.894,20
|
|
463
|
116
|
20028918-4
|
LYRICA - 25 mg - TABLETA / CAPSULA x 28
|
PFIZER
|
$
15.788,40
|
|
464
|
116
|
20028918-5
|
LYRICA - 25 mg - TABLETA / CAPSULA x 30
|
PFIZER
|
$
16.916,14
|
|
465
|
116
|
20028918-6
|
LYRICA - 25 mg - TABLETA / CAPSULA x 60
|
PFIZER
|
$
33.832,28
|
|
466
|
116
|
20041731-1
|
ALONO - 300 mg - TABLETA / CAPSULA x 6
|
PFIZER
|
$
40.598,74
|
|
467
|
116
|
20041731-13
|
ALONO - 300 mg - TABLETA / CAPSULA x 100
|
PFIZER
|
$
676.645,62
|
|
468
|
116
|
20041731-14
|
ALONO - 300 mg - TABLETA / CAPSULA x 200
|
PFIZER
|
$
1.353.291,24
|
|
469
|
116
|
20041731-2
|
ALONO - 300 mg - TABLETA / CAPSULA x 7
|
PFIZER
|
$
47.365,20
|
|
470
|
116
|
20041731-3
|
ALONO - 300 mg - TABLETA / CAPSULA x 14
|
PFIZER
|
$
94.730,39
|
|
471
|
116
|
20041731-4
|
ALONO - 300 mg - TABLETA / CAPSULA x 28
|
PFIZER
|
$
189.460,77
|
|
472
|
116
|
20041731-5
|
ALONO - 300 mg - TABLETA / CAPSULA x 30
|
PFIZER
|
$
202.993,68
|
|
473
|
116
|
20041731-6
|
ALONO - 300 mg - TABLETA / CAPSULA x 60
|
PFIZER
|
$
405.987,37
|
|
474
|
116
|
20041733-1
|
ALONO - 50 mg - TABLETA / CAPSULA x 6
|
PFIZER
|
$
6.766,46
|
|
475
|
116
|
20041733-13
|
ALONO - 50 mg - TABLETA / CAPSULA x 100
|
PFIZER
|
$
112.774,27
|
|
476
|
116
|
20041733-14
|
ALONO - 50 mg - TABLETA / CAPSULA x 200
|
PFIZER
|
$
225.548,54
|
|
477
|
116
|
20041733-2
|
ALONO - 50 mg - TABLETA / CAPSULA x 7
|
PFIZER
|
$
7.894,20
|
|
478
|
116
|
20041733-3
|
ALONO - 50 mg - TABLETA / CAPSULA x 14
|
PFIZER
|
$
15.788,40
|
|
479
|
116
|
20041733-4
|
ALONO - 50 mg - TABLETA / CAPSULA x 28
|
PFIZER
|
$
31.576,80
|
|
480
|
116
|
20041733-5
|
ALONO - 50 mg - TABLETA / CAPSULA x 30
|
PFIZER
|
$
33.832,28
|
|
481
|
116
|
20041733-6
|
ALONO - 50 mg - TABLETA / CAPSULA x 60
|
PFIZER
|
$
67.664,56
|
|
482
|
116
|
20041734-1
|
ALONO -150 mg - TABLETA / CAPSULA x 6
|
PFIZER
|
$
20.299,37
|
|
483
|
116
|
20041734-13
|
ALONO -150 mg - TABLETA / CAPSULA x 100
|
PFIZER
|
$
338.322,81
|
|
484
|
116
|
20041734-14
|
ALONO -150 mg - TABLETA / CAPSULA x 200
|
PFIZER
|
$
676.645,62
|
|
485
|
116
|
20041734-2
|
ALONO -150 mg - TABLETA / CAPSULA x 7
|
PFIZER
|
$
23.682,60
|
|
486
|
116
|
20041734-3
|
ALONO -150 mg - TABLETA / CAPSULA x 14
|
PFIZER
|
$
47.365,20
|
|
487
|
116
|
20041734-4
|
ALONO -150 mg - TABLETA / CAPSULA x 28
|
PFIZER
|
$
94.730,39
|
|
488
|
116
|
20041734-5
|
ALONO -150 mg - TABLETA / CAPSULA x 30
|
PFIZER
|
$
101.496,84
|
|
489
|
116
|
20041734-6
|
ALONO -150 mg - TABLETA / CAPSULA x 60
|
PFIZER
|
$
202.993,68
|
|
490
|
116
|
20041735-1
|
LYRICA - 50 mg - TABLETA / CAPSULA x 6
|
PFIZER
|
$
6.766,46
|
|
491
|
116
|
20041735-13
|
LYRICA - 50 mg - TABLETA / CAPSULA x 100
|
PFIZER
|
$
112.774,27
|
|
492
|
116
|
20041735-14
|
LYRICA - 50 mg - TABLETA / CAPSULA x 200
|
PFIZER
|
$
225.548,54
|
|
493
|
116
|
20041735-2
|
LYRICA - 50 mg - TABLETA / CAPSULA x 7
|
PFIZER
|
$
7.894,20
|
|
494
|
116
|
20041735-3
|
LYRICA - 50 mg - TABLETA / CAPSULA x 14
|
PFIZER
|
$
15.788,40
|
|
495
|
116
|
20041735-4
|
LYRICA - 50 mg - TABLETA / CAPSULA x 28
|
PFIZER
|
$
31.576,80
|
|
496
|
116
|
20041735-5
|
LYRICA - 50 mg - TABLETA / CAPSULA x 30
|
PFIZER
|
$
33.832,28
|
|
497
|
116
|
20041735-6
|
LYRICA - 50 mg - TABLETA / CAPSULA x 60
|
PFIZER
|
$
67.664,56
|
|
498
|
117
|
19999458-1
|
SEROQUEL XR - 400 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 10
|
ASTRAZENECA
|
$
100.176,82
|
|
499
|
117
|
19999458-2
|
SEROQUEL XR - 400 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 30
|
ASTRAZENECA
|
$
300.530,46
|
|
500
|
117
|
19999458-3
|
SEROQUEL XR - 400 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 60
|
ASTRAZENECA
|
$
601.060,92
|
|
501
|
117
|
19999459-1
|
SEROQUEL XR - 50 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 10
|
ASTRAZENECA
|
$
12.522,10
|
|
502
|
117
|
19999459-2
|
SEROQUEL XR - 50 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 30
|
ASTRAZENECA
|
$
37.566,31
|
|
503
|
117
|
19999459-3
|
SEROQUEL XR - 50 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 60
|
ASTRAZENECA
|
$
75.132,61
|
|
504
|
117
|
19999460-1
|
SEROQUEL XR - 200 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 10
|
ASTRAZENECA
|
$
50.088,41
|
|
505
|
117
|
19999460-2
|
SEROQUEL XR - 200 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 30
|
ASTRAZENECA
|
$
150.265,24
|
|
506
|
117
|
19999460-3
|
SEROQUEL XR - 200 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 60
|
ASTRAZENECA
|
$
300.530,46
|
|
507
|
117
|
19999461-1
|
SEROQUEL XR - 300 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 10
|
ASTRAZENECA
|
$
75.132,61
|
|
508
|
117
|
19999461-2
|
SEROQUEL XR - 300 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 30
|
ASTRAZENECA
|
$
225.397,85
|
|
509
|
117
|
19999461-3
|
SEROQUEL XR - 300 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 60
|
ASTRAZENECA
|
$
450.795,70
|
|
510
|
117
|
20035929-1
|
SEROQUEL XR - 150 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 10
|
ASTRAZENECA
|
$
37.566,31
|
|
511
|
117
|
20035929-2
|
SEROQUEL XR - 150 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 30
|
ASTRAZENECA
|
$
112.698,92
|
|
512
|
117
|
20037515-1
|
DRUGTECH QUETIDIN XR - 300 mg - TABLETA / CAPSULA DE
LIBERACION PROLONGADA x 30
|
SYNTHESIS
|
$
225.397,85
|
|
513
|
117
|
20037676-1
|
DRUGTECH QUETIDIN XR - 200 mg - TABLETA / CAPSULA DE
LIBERACION PROLONGADA x 30
|
SYNTHESIS
|
$
150.265,24
|
|
514
|
117
|
20037678-1
|
DRUGTECH QUETIDIN - 50 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 30
|
SYNTHESIS
|
$
37.566,31
|
|
515
|
117
|
20043686-1
|
KETIAN - 300 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 2
|
PROCAPS
|
$
15.026,53
|
|
516
|
117
|
20043686-10
|
KETIAN - 300 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 20
|
PROCAPS
|
$
150.265,24
|
|
517
|
117
|
20043686-11
|
KETIAN - 300 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 30
|
PROCAPS
|
$
225.397,85
|
|
518
|
117
|
20043686-12
|
KETIAN - 300 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 60
|
PROCAPS
|
$
450.795,70
|
|
519
|
117
|
20043686-2
|
KETIAN - 300 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 4
|
PROCAPS
|
$
30.053,04
|
|
520
|
117
|
20043686-3
|
KETIAN - 300 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 5
|
PROCAPS
|
$
37.566,31
|
|
521
|
117
|
20043686-4
|
KETIAN - 300 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 15
|
PROCAPS
|
$
112.698,92
|
|
522
|
117
|
20043686-5
|
KETIAN - 300 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 7
|
PROCAPS
|
$
52.592,83
|
|
523
|
117
|
20043686-6
|
KETIAN - 300 mg - TABLETA / CAPSU LA DE LIBERACION
PROLONGADA x 21
|
PROCAPS
|
$
157.778,49
|
|
524
|
117
|
20043686-8
|
KETIAN - 300 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 28
|
PROCAPS
|
$
210.371,32
|
|
525
|
117
|
20043686-9
|
KETIAN - 300 mg - TABLETA / CAPSULA DE LIBERACION PROLONGADA
x 10
|
PROCAPS
|
$
75.132,61
|
|
526
|
117
|
20043691-1
|
KETIAN - 200 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 2
|
PROCAPS
|
$
10.017,68
|
|
527
|
117
|
20043691-10
|
KETIAN - 200 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 30
|
PROCAPS
|
$
150.265,24
|
|
528
|
117
|
20043691-11
|
KETIAN - 200 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 60
|
PROCAPS
|
$
300.530,46
|
|
529
|
117
|
20043691-12
|
KETIAN - 200 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 30
|
PROCAPS
|
$
150.265,24
|
|
530
|
117
|
20043691-2
|
KETIAN - 200 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 4
|
PROCAPS
|
$
20.035,37
|
|
531
|
117
|
20043691-3
|
KETIAN - 200 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 5
|
PROCAPS
|
$
25.044,20
|
|
532
|
117
|
20043691-4
|
KETIAN - 200 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 15
|
PROCAPS
|
$ 75.132,61
|
|
533
|
117
|
20043691-5
|
KETIAN - 200 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 7
|
PROCAPS
|
$
35.061,89
|
|
534
|
117
|
20043691-6
|
KETIAN - 200 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 21
|
PROCAPS
|
$
105.185,67
|
|
535
|
117
|
20043691-7
|
KETIAN - 200 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 28
|
PROCAPS
|
$
140.247,55
|
|
536
|
117
|
20043691-8
|
KETIAN - 200 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 10
|
PROCAPS
|
$
50.088,41
|
|
537
|
117
|
20043691-9
|
KETIAN - 200 mg - TABLETA / CAPSULA DE LIBERACION PROLONGADA
x 20
|
PROCAPS
|
$
100.176,82
|
|
538
|
117
|
20043696-1
|
KETIAN - 400 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 2
|
PROCAPS
|
$
20.035,37
|
|
539
|
117
|
20043696-10
|
KETIAN - 400 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 30
|
PROCAPS
|
$
300.530,46
|
|
540
|
117
|
20043696-11
|
KETIAN - 400 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 60
|
PROCAPS
|
$
601.060,92
|
|
541
|
117
|
20043696-12
|
KETIAN - 400 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 30
|
PROCAPS
|
$
300.530,46
|
|
542
|
117
|
20043696-2
|
KETIAN - 400 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 4
|
PROCAPS
|
$
40.070,73
|
|
543
|
117
|
20043696-3
|
KETIAN - 400 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 5
|
PROCAPS
|
$
50.088,41
|
|
544
|
117
|
20043696-4
|
KETIAN - 400 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 15
|
PROCAPS
|
$
150.265,24
|
|
545
|
117
|
20043696-5
|
KETIAN - 400 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 7
|
PROCAPS
|
$
70.123,77
|
|
546
|
117
|
20043696-6
|
KETIAN - 400 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 21
|
PROCAPS
|
$
210.371,32
|
|
547
|
117
|
20043696-7
|
KETIAN - 400 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 28
|
PROCAPS
|
$
280.495,10
|
|
548
|
117
|
20043696-8
|
KETIAN - 400 mg - TABLETA / CAPSULA DE LIBERACION
PROLONGADA x 10
|
PROCAPS
|
$
100.176,82
|
|
549
|
117
|
20043696-9
|
KETIAN - 400 mg - TABLETA / CAPSULA DE LIBERACION PROLONGADA
x 20
|
PROCAPS
|
$
200.353,64
|
|
550
|
117
|
20043700-1
|
KETIAN - 50 mg - TABLETA / CAPSULA DE LIBERACION PROLONGADA
x 2
|
PROCAPS
|
$
2.504,42
|
|
551
|
117
|
20043700-10
|
KETIAN - 50 mg - TABLETA / CAPSULA DE LIBERACION PROLONGADA
x 30
|
PROCAPS
|
$
37.566,31
|
|
552
|
117
|
20043700-11
|
KETIAN - 50 mg - TABLETA / CAPSULA DE LIBERACION PROLONGADA
x 60
|
PROCAPS
|
$
75.132,61
|
|
553
|
117
|
20043700-2
|
KETIAN - 50 mg - TABLETA / CAPSULA DE LIBERACION PROLONGADA
x 4
|
PROCAPS
|
$
5.008,84
|
|
554
|
117
|
20043700-3
|
KETIAN - 50 mg - TABLETA / CAPSULA DE LIBERACION PROLONGADA
x 5
|
PROCAPS
|
$
6.261,05
|
|
555
|
117
|
20043700-4
|
KETIAN - 50 mg - TABLETA / CAPSULA DE LIBERACION PROLONGADA
x 15
|
PROCAPS
|
$
18.783,15
|
|
556
|
117
|
20043700-6
|
KETIAN - 50 mg - TABLETA / CAPSULA DE LIBERACION PROLONGADA
x 7
|
PROCAPS
|
$
8.765,48
|
|
557
|
117
|
20043700-6
|
KETIAN - 50 mg - TABLETA / CAPSULA DE LIBERACION PROLONGADA
x 21
|
PROCAPS
|
$
26.296,42
|
|
558
|
117
|
20043700-7
|
KETIAN - 50 mg - TABLETA / CAPSULA DE LIBERACION PROLONGADA
x 28
|
PROCAPS
|
$
35.061,89
|
|
559
|
117
|
20043700-8
|
KETIAN - 50 mg - TABLETA / CAPSULA DE LIBERACION PROLONGADA
x 10
|
PROCAPS
|
$
12.522,10
|
|
560
|
117
|
20043700-9
|
KETIAN - 50 mg - TABLETA / CAPSULA DE LIBERACION PROLONGADA
x 20
|
PROCAPS
|
$
25.044,20
|
|
561
|
117
|
20049701-1
|
DRUGTECH QUETIDIN XR - 150 mg - TABLETA/ CAPSULA DE
LIBERACION PROLONGADA x 7
|
SYNTHESIS
|
$
26.296,42
|
|
562
|
117
|
20049701-10
|
DRUGTECH QUETIDIN XR -150 mg - TABLETA / CAPSULA DE
LIBERACION PROLONGADA x 100
|
SYNTHESIS
|
$
375.663,07
|
|
563
|
117
|
20049701-11
|
DRUGTECH QUETIDIN XR -150 mg - TABLETA / CAPSULA DE
LIBERACION PROLONGADA x 200
|
SYNTHESIS
|
$
751.326,16
|
|
564
|
117
|
20049701-12
|
DRUGTECH QUETIDIN XR -150 mg - TABLETA / CAPSULA DE
LIBERACION PROLONGADA x 15
|
SYNTHESIS
|
$
56.349,46
|
|
565
|
117
|
20049701-13
|
DRUGTECH QUETIDIN XR -150 mg - TABLETA/ CAPSULA DE
LIBERACION PROLONGADA x 30
|
SYNTHESIS
|
$
112.698,92
|
|
566
|
117
|
20049701-2
|
DRUGTECH QUETIDIN XR -150 mg - TABLETA / CAPSULA DE
LIBERACION PROLONGADA x 10
|
SYNTHESIS
|
$
37.566,31
|
|
567
|
117
|
20049701-3
|
DRUGTECH QUETIDIN XR - 150 mg - TABLETA / CAPSULA DE
LIBERACION PROLONGADA x 20
|
SYNTHESIS
|
$
75.132,61
|
|
568
|
117
|
20049701-4
|
DRUGTECH QUETIDIN XR - 150 mg - TABLETA / CAPSULA DE
LIBERACION PROLONGADA x 40
|
SYNTHESIS
|
$
150.265,24
|
|
569
|
117
|
20049701-5
|
DRUGTECH QUETIDIN XR -150 mg - TABLETA / CAPSULA DE
LIBERACION PROLONGADA x 50
|
SYNTHESIS
|
$
187.831,54
|
|
570
|
117
|
20049701-6
|
DRUGTECH QUETIDIN XR -150 mg - TABLETA/ CAPSULA DE
LIBERACION PROLONGADA x 60
|
SYNTHESIS
|
$
225.397,85
|
|
571
|
117
|
20049701-7
|
DRUGTECH QUETIDIN XR - 150 mg - TABLETA/ CAPSULA DE
LIBERACION PROLONGADA x 70
|
SYNTHESIS
|
$
262.964,15
|
|
572
|
117
|
20049701-8
|
DRUGTECH QUETIDIN XR -150 mg - TABLETA / CAPSULA DE
LIBERACION PROLONGADA x 80
|
SYNTHESIS
|
$
300.530,46
|
|
573
|
117
|
20049701-9
|
DRUGTECH QUETIDIN XR -150 mg - TABLETA / CAPSULA DE
LIBERACION PROLONGADA x 90
|
SYNTHESIS
|
$
338.096,77
|
|
574
|
118
|
19949719-1
|
DRUGTECH QUETIDIN -100 mg - TABLETA / CAPSULA X15
|
SYNTHESIS
|
$
21.827,26
|
|
575
|
118
|
19949719-10
|
DRUGTECH QUETIDIN -100 mg - TABLETA / CAPSULA X40
|
SYNTHESIS
|
$
58.206,04
|
|
576
|
118
|
19949719-11
|
DRUGTECH QUETIDIN -100 mg - TABLETA / CAPSULA X 50
|
SYNTHESIS
|
$
72.757,54
|
|
577
|
118
|
19949719-12
|
DRUGTECH QUETIDIN -100 mg - TABLETA / CAPSULA X 70
|
SYNTHESIS
|
$
101.860,57
|
|
578
|
118
|
19949719-13
|
DRUGTECH QUETIDIN -100 mg - TABLETA / CAPSULA X 80
|
SYNTHESIS
|
$
116.412,07
|
|
579
|
118
|
19949719-14
|
DRUGTECH QUETIDIN -100 mg - TABLETA / CAPSULA X 90
|
SYNTHESIS
|
$
130.963,58
|
|
580
|
118
|
19949719-15
|
DRUGTECH QUETIDIN -100 mg - TABLETA / CAPSULA X 100
|
SYNTHESIS
|
$
145.515,08
|
|
581
|
118
|
19949719-16
|
DRUGTECH QUETIDIN -100 mg - TABLETA/ CAPSULA X 200
|
SYNTHESIS
|
$
291.030,18
|
|
582
|
118
|
19949719-2
|
DRUGTECH QUETIDIN -100 mg - TABLETA / CAPSULA X 30
|
SYNTHESIS
|
$
43.654,53
|
|
583
|
118
|
19949719-3
|
DRUGTECH QUETIDIN -100 mg - TABLETA / CAPSULA X 30
|
SYNTHESIS
|
$
43.654,53
|
|
584
|
118
|
19949719-4
|
DRUGTECH QUETIDIN -100 mg - TABLETA / CAPSULA X 60
|
SYNTHESIS
|
$
87.309,05
|
|
585
|
118
|
19949719-5
|
DRUGTECH QUETIDIN -100 mg - TABLETA / CAPSULA X 30
|
SYNTHESIS
|
$
43.654,53
|
|
586
|
118
|
19949719-6
|
DRUGTECH QUETIDIN -100 mg - TABLETA/ CAPSULA X15
|
SYNTHESIS
|
$
21.827,26
|
|
587
|
118
|
19949719-7
|
DRUGTECH QUETIDIN -100 mg - TABLETA/ CAPSULA X 7
|
SYNTHESIS
|
$
10.186,06
|
|
588
|
118
|
19949719-8
|
DRUGTECH QUETIDIN -100 mg - TABLETA/ CAPSULA X10
|
SYNTHESIS
|
$
14.551,51
|
|
589
|
118
|
19949719-9
|
DRUGTECH QUETIDIN -100 mg - TABLETA/ CAPSULA X 20
|
SYNTHESIS
|
$
29.103,01
|
|
590
|
118
|
19949721-1
|
DRUGTECH QUETIDIN - 200 mg - TABLETA / CAPSULA X15
|
SYNTHESIS
|
$
43.654,53
|
|
591
|
118
|
19949721-10
|
DRUGTECH QUETIDIN - 200 mg - TABLETA / CAPSULA X 40
|
SYNTHESIS
|
$
116.412,07
|
|
592
|
118
|
19949721-11
|
DRUGTECH QUETIDIN - 200 mg - TABLETA / CAPSULA X 50
|
SYNTHESIS
|
$
145.515,08
|
|
593
|
118
|
19949721-12
|
DRUGTECH QUETIDIN - 200 mg - TABLETA / CAPSULA X 70
|
SYNTHESIS
|
$
203.721,12
|
|
594
|
118
|
19949721-13
|
DRUGTECH QUETIDIN - 200 mg - TABLETA / CAPSULA X 80
|
SYNTHESIS
|
$
232.824,14
|
|
595
|
118
|
19949721-14
|
DRUGTECH QUETIDIN - 200 mg - TABLETA / CAPSULA X 90
|
SYNTHESIS
|
$
261.927,16
|
|
596
|
118
|
19949721-15
|
DRUGTECH QUETIDIN - 200 mg - TABLETA / CAPSULA X 100
|
SYNTHESIS
|
$
291.030,18
|
|
597
|
118
|
19949721-16
|
DRUGTECH QUETIDIN - 200 mg - TABLETA / CAPSULA X 200
|
SYNTHESIS
|
$
582.060,35
|
|
598
|
118
|
19949721-2
|
DRUGTECH QUETIDIN - 200 mg - TABLETA / CAPSULA X30
|
SYNTHESIS
|
$
87.309,05
|
|
599
|
118
|
19949721-3
|
DRUGTECH QUETIDIN - 200 mg - TABLETA / CAPSULA X 30
|
SYNTHESIS
|
$
87.309,05
|
|
600
|
118
|
19949721-4
|
DRUGTECH QUETIDIN - 200 mg - TABLETA / CAPSULA X 15
|
SYNTHESIS
|
$
43.654,53
|
|
601
|
118
|
19949721-5
|
DRUGTECH QUETIDIN - 200 mg - TABLETA / CAPSULA X 30
|
SYNTHESIS
|
$
87.309,05
|
|
602
|
118
|
19949721-6
|
DRUGTECH QUETIDIN - 200 mg - TABLETA / CAPSULA X60
|
SYNTHESIS
|
$
174.618,11
|
|
603
|
118
|
19949721-7
|
DRUGTECH QUETIDIN - 200 mg - TABLETA / CAPSULA X 7
|
SYNTHESIS
|
$
20.372,11
|
|
604
|
118
|
19949721-8
|
DRUGTECH QUETIDIN - 200 mg - TABLETA / CAPSULA X10
|
SYNTHESIS
|
$
29.103,01
|
|
605
|
118
|
19949721-9
|
DRUGTECH QUETIDIN - 200 mg - TABLETA / CAPSULA X 20
|
SYNTHESIS
|
$
58.206,04
|
|
606
|
118
|
19949755-1
|
DRUGTECH QUETIDIN - 25 mg - TABLETA / CAPSULA X 30
|
SYNTHESIS
|
$
10.913,63
|
|
607
|
118
|
19949755-10
|
DRUGTECH QUETIDIN - 25 mg - TABLETA / CAPSULA X 50
|
SYNTHESIS
|
$
18.189,38
|
|
608
|
118
|
19949755-11
|
DRUGTECH QUETIDIN - 25 mg - TABLETA / CAPSULA X70
|
SYNTHESIS
|
$
25.465,14
|
|
609
|
118
|
19949755-12
|
DRUGTECH QUETIDIN - 25 mg - TABLETA / CAPSULA X 80
|
SYNTHESIS
|
$
29.103,01
|
|
610
|
118
|
19949755-13
|
DRUGTECH QUETIDIN - 25 mg - TABLETA / CAPSULA X90
|
SYNTHESIS
|
$
32.740,90
|
|
611
|
118
|
19949755-14
|
DRUGTECH QUETIDIN - 25 mg - TABLETA / CAPSULA X 100
|
SYNTHESIS
|
$
36.378,78
|
|
612
|
118
|
19949755-15
|
DRUGTECH QUETIDIN - 25 mg - TABLETA / CAPSULA X 200
|
SYNTHESIS
|
$
72.757,54
|
|
613
|
118
|
19949755-2
|
DRUGTECH QUETIDIN - 25 mg - TABLETA / CAPSULA X 60
|
SYNTHESIS
|
$
21.827,26
|
|
614
|
118
|
19949755-3
|
DRUGTECH QUETIDIN - 25 mg - TABLETA / CAPSULA X15
|
SYNTHESIS
|
$
5.456,81
|
|
615
|
118
|
19949755-4
|
DRUGTECH QUETIDIN - 25 mg - TABLETA / CAPSULA X 30
|
SYNTHESIS
|
$
10.913,63
|
|
616
|
118
|
19949755-5
|
DRUGTECH QUETIDIN - 25 mg - TABLETA / CAPSULA X 60
|
SYNTHESIS
|
$
21.827,26
|
|
617
|
118
|
19949755-6
|
DRUGTECH QUETIDIN - 25 mg - TABLETA / CAPSULA X7
|
SYNTHESIS
|
$
2.546,51
|
|
618
|
118
|
19949755-7
|
DRUGTECH QUETIDIN - 25 mg - TABLETA / CAPSULA X10
|
SYNTHESIS
|
$
3.637,88
|
|
619
|
118
|
19949755-8
|
DRUGTECH QUETIDIN - 25 mg - TABLETA / CAPSULA X 20
|
SYNTHESIS
|
$
7.275,75
|
|
620
|
118
|
19949755-9
|
DRUGTECH QUETIDIN - 25 mg - TABLETA / CAPSULA X40
|
SYNTHESIS
|
$
14.551,51
|
|
621
|
118
|
19960787-1
|
SEROQUEL - 300 mg - TABLETA / CAPSULA x 30
|
ASTRAZENECA
|
$
130.963,58
|
|
622
|
118
|
19960787-3
|
SEROQUEL - 300 mg - TABLETA / CAPSULA x 30
|
ASTRAZENECA
|
$
130.963,58
|
|
623
|
118
|
19976916-1
|
DRUGTECH QUETIDIN - 300 mg - TABLETA / CAPSULA X10
|
SYNTHESIS
|
$ 43.654,53
|
|
624
|
118
|
19976916-10
|
DRUGTECH QUETIDIN - 300 mg - TABLETA / CAPSULA X 80
|
SYNTHESIS
|
$
349.236,22
|
|
625
|
118
|
19976916-11
|
DRUGTECH QUETIDIN - 300 mg - TABLETA /CAPSULA X 90
|
SYNTHESIS
|
$
392.890,73
|
|
626
|
118
|
19976916-12
|
DRUGTECH QUETIDIN - 300 mg - TABLETA / CAPSULA X100
|
SYNTHESIS
|
$
$ 436.545,26
|
|
627
|
118
|
19976916-13
|
DRUGTECH QUETIDIN - 300 mg - TABLETA / CAPSULA X 200
|
SYNTHESIS
|
$
$ 873.090,53
|
|
628
|
118
|
19976916-2
|
DRUGTECH QUETIDIN - 300 mg - TABLETA / CAPSULA X20
|
SYNTHESIS
|
$
$ 87.309,05
|
|
629
|
118
|
19976916-3
|
DRUGTECH QUETIDIN - 300 mg - TABLETA / CAPSULA X30
|
SYNTHESIS
|
$
$ 130.963,58
|
|
630
|
118
|
19976916-4
|
DRUGTECH QUETIDIN - 300 mg - TABLETA / CAPSULA X 7
|
SYNTHESIS
|
$
$ 30.558,17
|
|
631
|
118
|
19976916-5
|
DRUGTECH QUETIDIN - 300 mg - TABLETA / CAPSULA X15
|
SYNTHESIS
|
$
$ 65.481,79
|
|
632
|
118
|
19976916-6
|
DRUGTECH QUETIDIN - 300 mg - TABLETA / CAPSULA X40
|
SYNTHESIS
|
$
$ 174.618,11
|
|
633
|
118
|
19976916-7
|
DRUGTECH QUETIDIN - 300 mg - TABLETA / CAPSULA X 50
|
SYNTHESIS
|
$
$ 218.272,63
|
|
634
|
118
|
19976916-8
|
DRUGTECH QUETIDIN - 300 mg - TABLETA / CAPSULA X60
|
SYNTHESIS
|
$
$ 261.927,16
|
|
635
|
118
|
19976916-9
|
DRUGTECH QUETIDIN - 300 mg - TABLETA / CAPSULA X 70
|
SYNTHESIS
|
$
$ 305.581,69
|
|
636
|
118
|
19995113-1
|
QUETIAPINA - 25 mg - TABLETA / CAPSULA x 7
|
TECNOQUIMICAS
|
$
$ 2.546,51
|
|
637
|
118
|
19995113-10
|
QUETIAPINA - 25 mg - TABLETA / CAPSULA x 90
|
TECNOQUIMICAS
|
$
$ 32.740,90
|
|
638
|
118
|
19995113-11
|
QUETIAPINA - 25 mg - TABLETA / CAPSULA x 100
|
TECNOQUIMICAS
|
$
$ 36.378,78
|
|
639
|
118
|
19995113-2
|
QUETIAPINA - 25 mg - TABLETA / CAPSULA x 14
|
TECNOQUIMICAS
|
$
$ 5.093,02
|
|
640
|
11.8
|
19995113-3
|
QUETIAPINA - 25 mg - TABLETA / CAPSULA x 21
|
TECNOQUIMICAS
|
$
$ 7.639,54
|
|
641.
|
118
|
19995113-4
|
QUETIAPINA - 25 mg - TABLETA / CAPSULA x 10
|
TECNOQUIMICAS
|
$
$ 3.637,88
|
|
642
|
118
|
19995113-5
|
QUETIAPINA - 25 mg - TABLETA / CAPSULA x 20
|
TECNOQUIMICAS
|
$
$ 7.275,75
|
|
643
|
118
|
19995113-6
|
QUETIAPINA - 25 mg - TABLETA / CAPSULA x 30
|
TECNOQUIMICAS
|
$
$ 10.913,63
|
|
644
|
118
|
19995113-7
|
QUETIAPINA - 25 mg - TABLETA / CAPSULA x 40
|
TECNOQUIMICAS
|
$
$ 14.551,51
|
|
645
|
118
|
19995113-9
|
QUETIAPINA - 25 mg - TABLETA / CAPSULA x 60
|
TECNOQUIMICAS
|
$
$ 21.827,26
|
|
646
|
118
|
19995320-1
|
QUETIAPINA - 200 mg - TABLETA / CAPSULA x 7
|
TECNOQUIMICAS
|
$
$ 20.372,11
|
|
647
|
118
|
19995320-10
|
QUETIAPINA - 200 mg - TABLETA / CAPSULA x 100
|
TECNOQUIMICAS
|
$
$ 291.030,18
|
|
648
|
118
|
19995320-11
|
QUETIAPINA - 200 mg - TABLETA / CAPSULA x 40
|
TECNOQUIMICAS
|
$
$ 116.412,07
|
|
649
|
118
|
19995320-2
|
QUETIAPINA - 200 mg - TABLETA / CAPSULA x 10
|
TECNOQUIMICAS
|
$
$ 29.103,01
|
|
650
|
118
|
19995320-4
|
QUETIAPINA - 200 mg - TABLETA / CAPSULA x 60
|
TECNOQUIMICAS
|
$
$ 174.618,11
|
|
651
|
118
|
19995320-5
|
QUETIAPINA - 200 mg - TABLETA / CAPSULA x 14
|
TECNOQUIMICAS
|
$
$ 40.744,23
|
|
652
|
118
|
19995320-6
|
QUETIAPINA - 200 mg - TABLETA / CAPSULA x 21
|
TECNOQUIMICAS
|
$
$ 61.116,34
|
|
653
|
118
|
19995320-7
|
QUETIAPINA - 200 mg - TABLETA / CAPSULA x 20
|
TECNOQUIMICAS
|
$
$ 58.206,04
|
|
654
|
118
|
19995320-9
|
QUETIAPINA - 200 mg - TABLETA / CAPSULA x 90
|
TECNOQUIMICAS
|
$
$ 261.927,16
|
|
655
|
118
|
19996292-1
|
QUETIAPINA -100 mg - TABLETA / CAPSULA x 2
|
TECNOQUIMICAS
|
$
$ 2.910,30
|
|
656
|
118
|
19996292-10
|
QUETIAPINA -100 mg - TABLETA / CAPSULA x 90
|
TECNOQUIMICAS
|
$
$ 130.963,58
|
|
657
|
118
|
19996292-11
|
QUETIAPINA -100 mg - TABLETA / CAPSULA x 100
|
TECNOQUIMICAS
|
$
$ 145.515,08
|
|
658
|
118
|
19996292-2
|
QUETIAPINA -100 mg - TABLETA / CAPSULA x 7
|
TECNOQUIMICAS
|
$
$ 10.186,06
|
|
659
|
118
|
19996292-3
|
QUETIAPINA - 100 mg - TABLETA / CAPSULA x 14
|
TECNOQUIMICAS
|
$
$ 20.372,11
|
|
660
|
118
|
19996292-4
|
QUETIAPINA - 100 mg - TABLETA / CAPSULA x 21
|
TECNOQUIMICAS
|
$
$ 30.558,17
|
|
661
|
118
|
19996292-5
|
QUETIAPINA -100 mg - TABLETA / CAPSULA x 10
|
TECNOQUIMICAS
|
$
$ 14.551,51
|
|
662
|
118
|
19996292-6
|
QUETIAPINA -100 mg - TABLETA / CAPSULA x 20
|
TECNOQUIMICAS
|
$
$ 29.103,01
|
|
663
|
118
|
19996292-7
|
QUETIAPINA -100 mg - TABLETA / CAPSULA x 30
|
TECNOQUIMICAS
|
$
$ 43.654,53
|
|
664
|
118
|
19996292-8
|
QUETIAPINA - 100 mg - TABLETA / CAPSULA x 40
|
TECNOQUIMICAS
|
$ $
58.206,04
|
|
665
|
118
|
19996292-9
|
QUETIAPINA -100 mg - TABLETA / CAPSULA X 60
|
TECNOQUIMICAS
|
$
$ 87.309,05
|
|
666
|
118
|
19996348-1
|
QUETIAPINA - 300 mg - TABLETA / CAPSULA x 7
|
TECNOQUIMICAS
|
$
$ 30.558,17
|
|
667
|
118
|
19996348-10
|
QUETIAPINA - 300 mg - TABLETA / CAPSULA x 100
|
TECNOQUIMICAS
|
$
$ 436.545,26
|
|
668
|
118
|
19996348-2
|
QUETIAPINA - 300 mg - TABLETA / CAPSULA x 14
|
TECNOQUIMICAS
|
$
$ 61.116,34
|
|
669
|
118
|
19996348-3
|
QUETIAPINA - 300 mg - TABLETA / CAPSULA x 21
|
TECNOQUIMICAS
|
$
$ 91.674,51
|
|
670
|
118
|
19996348-4
|
QUETIAPINA - 300 mg - TABLETA / CAPSULA x 10
|
TECNOQUIMICAS
|
$
$ 43.654,53
|
|
671
|
118
|
19996348-5
|
QUETIAPINA - 300 mg - TABLETA / CAPSULA x 20
|
TECNOQUIMICAS
|
$
$ 87.309,05
|
|
672
|
118
|
19996348-7
|
QUETIAPINA - 300 mg - TABLETA / CAPSULA x 40
|
TECNOQUIMICAS
|
$
$ 174.618,11
|
|
673
|
118
|
19996348-8
|
QUETIAPINA - 300 mg - TABLETA / CAPSULA x 60
|
TECNOQUIMICAS
|
$
$ 261.927,16
|
|
674
|
118
|
19996348-9
|
QUETIAPINA - 300 mg - TABLETA / CAPSULA x 90
|
TECNOQUIMICAS
|
$
$ 392.890,73
|
|
675
|
118
|
224715-1
|
SEROQUEL -100 mg - TABLETA / CAPSULA x 10
|
ASTRAZENECA
|
$
$ 14.551,51
|
|
676
|
118
|
224715-5
|
SEROQUEL -100 mg - TABLETA / CAPSULA x 20
|
ASTRAZENECA
|
$
$ 29.103,01
|
|
677
|
118
|
224715-6
|
SEROQUEL -100 mg - TABLETA / CAPSULA x 30
|
ASTRAZENECA
|
$
$ 43.654,53
|
|
678
|
118
|
224715-7
|
SEROQUEL -100 mg - TABLETA / CAPSULA x 60
|
ASTRAZENECA
|
$
$ 87.309,05
|
|
679
|
118
|
224715-8
|
SEROQUEL -100 mg - TABLETA / CAPSULA x 90
|
ASTRAZENECA
|
$
$ 130.963,58
|
|
680
|
118
|
224717-3
|
SEROQUEL - 200 mg - TABLETA / CAPSULA x 10
|
ASTRAZENECA
|
$
$ 29.103,01
|
|
681
|
118
|
224717-4
|
SEROQUEL - 200 mg - TABLETA / CAPSULA x 20
|
ASTRAZENECA
|
$
$ 58.206,04
|
|
682
|
118
|
224717-5
|
SEROQUEL - 200 mg - TABLETA / CAPSULA x 30
|
ASTRAZENECA
|
$
$ 87.309,05
|
|
683
|
118
|
224717-6
|
SEROQUEL - 200 mg - TABLETA / CAPSULA x 60
|
ASTRAZENECA
|
$
$ 174.618,11
|
|
684
|
118
|
224717-7
|
SEROQUEL - 200 mg - TABLETA / CAPSULA x 90
|
ASTRAZENECA
|
$
$ 261.927,16
|
|
685
|
118
|
224719-3
|
SEROQUEL - 25 mg - TABLETA / CAPSULA x 10
|
ASTRAZENECA
|
$
$ 3.637,88
|
|
686
|
118
|
224719-4
|
SEROQUEL - 25 mg - TABLETA / CAPSULA x 20
|
ASTRAZENECA
|
$
$ 7.275,75
|
|
687
|
118
|
224719-5
|
SEROQUEL - 25 mg - TABLETA / CAPSULA x 30
|
ASTRAZENECA
|
$
$ 10.913,63
|
|
688
|
118
|
224719-6
|
SEROQUEL - 25 mg - TABLETA / CAPSULA x 60
|
ASTRAZENECA
|
$
$ 21.827,26
|
|
689
|
118
|
224719-7
|
SEROQUEL - 25 mg - TABLETA / CAPSULA x 90
|
ASTRAZENECA
|
$
$ 32.740,90
|
|
690
|
120
|
19985874-1
|
EXELON - 9 mg - TRANSDERMICOS x 3
|
NOVARTIS
|
$
$ 14.178,97
|
|
691
|
120
|
19985874-2
|
EXELON - 9 mg - TRANSDERMICOS x 7
|
NOVARTIS
|
$
$ 33.084,29
|
|
692
|
120
|
19985874-3
|
EXELON - 9 mg - TRANSDERMICOS x 15
|
NOVARTIS
|
$
$ 70.894,90
|
|
693
|
120
|
19985874-4
|
EXELON - 9 mg - TRANSDERMICOS x 30
|
NOVARTIS
|
$
$ 141.789,78
|
|
694
|
120
|
19985874-5
|
EXELON - 9 mg - TRANSDERMICOS x 60
|
NOVARTIS
|
$
$ 283.579,57
|
|
695
|
120
|
19985874-6
|
EXELON - 9 mg - TRANSDERMICOS x 100
|
NOVARTIS
|
$
$ 472.632,62
|
|
696
|
120
|
19985985-1
|
EXELON - 36 mg - TRANSDERMICOS x 3
|
NOVARTIS
|
$
56.715,91
|
|
697
|
120
|
19985985-2
|
EXELON - 36 mg - TRANSDERMICOS x 7
|
NOVARTIS
|
$
132.337,13
|
|
698
|
120
|
19985985-3
|
EXELON - 36 mg - TRANSDERMICOS x 15
|
NOVARTIS
|
$
283.579,57
|
|
699
|
120
|
19985985-4
|
EXELON - 36 mg - TRANSDERMICOS x 30
|
NOVARTIS
|
$
567.159,14
|
|
700
|
120
|
19985985-5
|
EXELON - 36 mg - TRANSDERMICOS x 60
|
NOVARTIS
|
$
1.134.318,29
|
|
701
|
120
|
19985985-6
|
EXELON - 36 mg - TRANSDERMICOS x 100
|
NOVARTIS
|
$
1.890.530,49
|
|
702
|
120
|
19985986-2
|
EXELON - 27 mg - TRANSDERMICOS x 7
|
NOVARTIS
|
$
99.252,85
|
|
703
|
120
|
19985986-3
|
EXELON - 27 mg - TRANSDERMICOS x 15
|
NOVARTIS
|
$
212.684,68
|
|
704
|
120
|
19985986-4
|
EXELON - 27 mg - TRANSDERMICOS x 30
|
NOVARTIS
|
$
425.369,35
|
|
705
|
120
|
19985986-5
|
EXELON - 27 mg - TRANSDERMICOS x 60
|
NOVARTIS
|
$
850.738,72
|
|
706
|
120
|
19985986-6
|
EXELON - 27 mg - TRANSDERMICOS x 100
|
NOVARTIS
|
$
1.417.897,86
|
|
707
|
120
|
19985987-1
|
EXELON -18 mg - TRANSDERMICOS x 3
|
NOVARTIS
|
$
28.357,96
|
|
708
|
120
|
19985987-2
|
EXELON -18 mg - TRANSDERMICOS x 7
|
NOVARTIS
|
$
66.168,57
|
|
709
|
120
|
19985987-3
|
EXELON -18 mg - TRANSDERMICOS x 15
|
NOVARTIS
|
$
141.789,78
|
|
710
|
120
|
19985987-4
|
EXELON -18 mg - TRANSDERMICOS x 30
|
NOVARTIS
|
$
283.579,57
|
|
711
|
120
|
19985987-5
|
EXELON -18 mg - TRANSDERMICOS x 60
|
NOVARTIS
|
$
567.159,14
|
|
712
|
120
|
19985987-6
|
EXELON -18 mg - TRANSDERMICOS x 100
|
NOVARTIS
|
$
945.265,24
|
|
713
|
121
|
20008022-1
|
EXELON - 4,5 mg - TABLETA / CAPSULA x 14
|
NOVARTIS
|
$
57.253,05
|
|
714
|
121
|
20008022-2
|
EXELON - 4,5 mg - TABLETA / CAPSULA x 28
|
NOVARTIS
|
$
114.506,08
|
|
715
|
121
|
20008022-3
|
EXELON - 4,5 mg - TABLETA / CAPSULA x 56
|
NOVARTIS
|
$
229.012,16
|
|
716
|
121
|
20008022-4
|
EXELON - 4,5 mg - TABLETA / CAPSULA x 112
|
NOVARTIS
|
$
458.024,32
|
|
717
|
121
|
20008023-1
|
EXELON -1,5 mg - TABLETA / CAPSULA x 14
|
NOVARTIS
|
$
19.084,35
|
|
718
|
121
|
20008023-2
|
EXELON -1,5 mg - TABLETA / CAPSULA x 28
|
NOVARTIS
|
$
38.168,69
|
|
719
|
121
|
20008023-3
|
EXELON -1.5 mg - TABLETA / CAPSULA x 56
|
NOVARTIS
|
$
76.337,39
|
|
720
|
121
|
20008023-4
|
EXELON -1,5 mg - TABLETA / CAPSULA x 112
|
NOVARTIS
|
$
152.674,77
|
|
721
|
121
|
20008025-1
|
EXELON - 3 mg - TABLETA / CAPSULA x 14
|
NOVARTIS
|
$
38.168,69
|
|
722
|
121
|
20008025-2
|
EXELON - 3 mg - TABLETA / CAPSULA x 28
|
NOVARTIS
|
$
76.337,39
|
|
723
|
121
|
20008025-3
|
EXELON - 3 mg - TABLETA / CAPSULA x 56
|
NOVARTIS
|
$
152.674,77
|
|
724
|
121
|
20008025-4
|
EXELON - 3 mg - TABLETA / CAPSULA x 112
|
NOVARTIS
|
$
305.349,55
|
|
725
|
121
|
20008026-1
|
EXELON - 6 mg - TABLETA / CAPSULA x 112
|
NOVARTIS
|
$
610.699,09
|
|
726
|
121
|
20008026-2
|
EXELON - 6 mg - TABLETA / CAPSULA x 14
|
NOVARTIS
|
$
76.337,39
|
|
727
|
121
|
20008026-3
|
EXELON - 6 mg - TABLETA / CAPSULA x 28
|
NOVARTIS
|
$
152.674,77
|
|
728
|
121
|
20008026-4
|
EXELON - 6 mg - TABLETA / CAPSULA x 56
|
NOVARTIS
|
$
305.349,55
|
|
729
|
121
|
20018590-1
|
RIVAMER -1,5 mg - TABLETA / CAPSULA x 30
|
SUN PHARMACEUTIC AL
|
$
40.895,02
|
|
730
|
121
|
20018593-1
|
RIVAMER - 4,5 mg - TABLETA / CAPSULA x 30
|
SUN PHARMACEUTIC AL
|
$
122.685,09
|
|
731
|
121
|
20018595-1
|
RIVAMER - 3 mg - TABLETA / CAPSULA x 30
|
SUN PHARMACEUTIC AL
|
$
81.790,06
|
|
732
|
121
|
20038208-1
|
IVASTIKLINE - 3 mg - TABLETA / CAPSULA x 28
|
GLAXOSMITHKLI NE
|
$
76.337,39
|
|
733
|
121
|
20038208-2
|
IVASTIKLINE - 3 mg - TABLETA / CAPSULA x 30
|
GLAXOSMITHKLI NE
|
$
81.790,06
|
|
734
|
121
|
20038210-1
|
IVASTIKLINE - 1,5 mg - TABLETA / CAPSULA x 28
|
GLAXOSMITHKLI NE
|
$ 38.168,69
|
|
735
|
121
|
20038210-2
|
IVASTIKLINE -1,5 mg - TABLETA / CAPSULA x 30
|
GLAXOSMITHKLI NE
|
$
40.895,02
|
|
736
|
121
|
20038210-3
|
IVASTIKLINE -1,5 mg - TABLETA / CAPSULA x 28
|
GLAXOSMITHKLI NE
|
$
38.168,69
|
|
737
|
121
|
20038210-4
|
IVASTIKLINE - 1,5 mg - TABLETA / CAPSULA x 30
|
GLAXOSMITHKLI NE
|
$
40.895,02
|
|
738
|
121
|
20038211-1
|
IVASTIKLINE - 6 mg - TABLETA / CAPSULA x 28
|
GLAXOSMITHKLI NE
|
$
152.674,77
|
|
739
|
121
|
20038211-2
|
IVASTIKLINE - 6 mg - TABLETA / CAPSULA x 30
|
GLAXOSMITHKLI NE
|
$
163.580,12
|
|
740
|
121
|
20038213-1
|
IVASTIKLINE - 4,5 mg - TABLETA / CAPSULA x 28
|
GLAXOSMITHKLI NE
|
$
114.506,08
|
|
741
|
121
|
20038213-2
|
IVASTIKLINE - 4,5 mg - TABLETA / CAPSULA x 30
|
GLAXOSMITHKLI NE
|
$
122.685,09
|
|
742
|
126
|
228406-1
|
AGRASTAT -12,5 mg - 50 mi - 0,25 mg/ml -SOLUCION /
SUSPENSION INYECTABLE x 1
|
ASPEN
|
$
536.523,20
|
|
743
|
127
|
19971860-1
|
THYROGEN -1,1 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 2
|
GENZYME
|
$
2.403.102,88
|
|
744
|
129
|
19997476-1
|
YONDELIS -1 mg - POLVO RECONSTITUIR A SOLUCION / SUSPENSION
INYECTABLE x 1
|
JANSSEN
|
$
5.275.977,00
|
|
745
|
129
|
19997476-2
|
YONDELIS -1 mg - POLVO RECONSTITUIRA SOLUCION / SUSPENSION
INYECTABLE x 2
|
JANSSEN
|
$
10.551.953,99
|
|
746
|
129
|
19997476-3
|
YONDELIS -1 mg - POLVO RECONSTITUIR A SOLUCION / SUSPENSION
INYECTABLE x 3
|
JANSSEN
|
$
15.827.930,98
|
|
747
|
129
|
19997476-4
|
YONDELIS -1 mg - POLVO RECONSTITUIRA SOLUCION / SUSPENSION
INYECTABLE x 5
|
JANSSEN
|
$
26.379.884,97
|
|
748
|
129
|
19997476-5
|
YONDELIS -1 mg - POLVO RECONSTITUIRA SOLUCION / SUSPENSION
INYECTABLE x 10
|
JANSSEN
|
$
52.759.769,95
|
|
749
|
130
|
20009810-1
|
STELARA - 45 mg - 0,5 mi - 90 mg/ml - SOLUCION / SUSPENSION
INYECTABLE x 1
|
JANSSEN
|
$
8.639.108,99
|
|
750
|
130
|
20009810-2
|
STELARA - 45 mg - 0,5 mi - 90 mg/ml - SOLUCION / SUSPENSION
INYECTABLE x 2
|
JANSSEN
|
$
17.278.217,97
|
|
751
|
130
|
20009810-3
|
STELARA - 45 mg - 0,5 mi - 90 mg/ml - SOLUCION / SUSPENSION
INYECTABLE x 3
|
JANSSEN
|
$
25.917.327,39
|
|
752
|
130
|
20009810-4
|
STELARA - 45 mg - 0,5 mi - 90 mg/ml - SOLUCION / SUSPENSION
INYECTABLE x 10
|
JANSSEN
|
$
86.391.089,70
|
|
753
|
132
|
19962384-1
|
HUMALOG MIX 25 - 300 U -3 mi - 100 U/ml -SOLUCION / SUSPENSION
INYECTABLE x 2
|
ELI-LILLY
|
$
37.834,70
|
|
754
|
132
|
19962384-2
|
HUMALOG MIX 25 - 300 U -3 mi - 100 U/ml -SOLUCION /
SUSPENSION INYECTABLE x 5
|
ELI-LILLY
|
$
94.586,75
|
|
755
|
132
|
19962384-3
|
HUMALOG MIX 25 - 300 U -3 mi -100 U/ml -SOLUCION /
SUSPENSION INYECTABLE x 5
|
ELI-LILLY
|
$
94.586,75
|
|
756
|
^32
|
19962384-4
|
HUMALOG MIX 25 - 300 U -3 mi -100 U/ml -SOLUCION /
SUSPENSION INYECTABLE x 1
|
ELI-LILLY
|
$
18.917,35
|
|
757
|
132
|
19962384-5
|
HUMALOG MIX 25 - 300 U -3 mi -100 U/ml -SOLUCION /
SUSPENSION INYECTABLE x 2
|
ELI-LILLY
|
$
37.834,70
|
|
758
|
132
|
19989587-1
|
HUMALOG MIX 50 - 300 U -3 mi -100 U/ml -SOLUCION /
SUSPENSION INYECTABLE x 5
|
ELI-LILLY
|
$
94.586,75
|
|
759
|
132
|
19989587-2
|
HUMALOG MIX 50 - 300 U -3 mi -100 U/ml -SOLUCION /
SUSPENSION INYECTABLE x 5
|
ELI-LILLY
|
$
94.586,75
|
|
760
|
132
|
19989587-3
|
HUMALOG MIX 50 - 300 U -3 mi - 100 U/ml -SOLUCION /
SUSPENSION INYECTABLE x 1
|
ELI-LILLY
|
$
18.917,35
|
|
761
|
132
|
19989587-4
|
HUMALOG MIX 50 - 300 U -3 mi - 100 U/ml -SOLUCION /
SUSPENSION INYECTABLE x 2
|
ELI-LILLY
|
$
37.834,70
|
|
762
|
133
|
19935850-1
|
IMMUNATE - 500 /400 Ul - 5 mi - POLVO RECONSTITUIR A
SOLUCION / SUSPENSION INYECTABLE x 1
|
BAXTER
|
$
487.787,21
|
|
763
|
133
|
19935853-1
|
IMMUNATE - 1000 /800 Ul -10 mi -POLVO RECONSTITUIR A
SOLUCION / SUSPENSION INYECTABLE x 1
|
BAXTER
|
$
975.574,43
|
|
764
|
133
|
226750-1
|
IMMUNATE - 250 /200 Ul - 5 mi - POLVO RECONSTITUIR A
SOLUCION / SUSPENSION INYECTABLE x 1
|
BAXTER
|
$
243.893,60
|
|
765
|
119a
|
19998726-1
|
XARELTO -10 mg - TABLETA / CAPSULA x 5
|
BAYER
|
$
30.630,11
|
|
766
|
119a
|
19998726-2
|
XARELTO -10 mg - TABLETA / CAPSULA x 10
|
BAYER
|
$
61.260,23
|
|
767
|
119a
|
19998726-3
|
XARELTO -10 mg - TABLETA / CAPSULA x 30
|
BAYER
|
$
183.780,67
|
|
768
|
119b
|
20029236-1
|
XARELTO -15 mg - TABLETA / CAPSULA x 14
|
BAYER
|
$
84.979,94
|
|
769
|
119b
|
20029236-2
|
XARELTO -15 mg - TABLETA / CAPSULA x 28
|
BAYER
|
$
169.959,88
|
|
770
|
119c
|
20029235-1
|
XARELTO - 20 mg - TABLETA / CAPSULA x 14
|
BAYER
|
$
85.764,31
|
|
771
|
119c
|
20029235-2
|
XARELTO - 20 mg - TABLETA / CAPSULA x 28
|
BAYER
|
$
171.528,63
|
|
772
|
128a
|
19913029-1
|
DYSPORT - 500 Ul - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 1
|
IPSEN
|
$
563.847,30
|
|
773
|
128a
|
20032324-1
|
DYSPORT - 300 U - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 1
|
IPSEN
|
$
338.308,38
|
|
774
|
128b
|
20004997-1
|
BOTOX - 50 Ul - POLVO RECONSTITUIR A SOLUCION / SUSPENSION
INYECTABLE x 1 -
|
ALLERGAN
|
$
267.608,81
|
|
775
|
128b
|
20019432-1
|
BOTOX - 200 Ul - POLVO RECONSTITUIR A SOLUCION / SUSPENSION
INYECTABLE x 1
|
ALLERGAN
|
$
1.070.435,25
|
|
776
|
128b
|
45122-1
|
BOTOX -100 Ul - POLVO RECONSTITUIR A SOLUCION / SUSPENSION
INYECTABLE x 1
|
ALLERGAN
|
$
535.217,63
|
|
777
|
32a
|
19999701-1
|
REVLIMID de 5 mg; TABLETA / CÁPSULA; x 21
|
CELGENE EUROPE LIMITED
|
$
12.477.883,53
|
|
778
|
32b
|
19999700-1
|
REVLIMID de 10 mg; TABLETA / CÁPSULA; x 21
|
CELGENE EUROPE LIMITED
|
$
13.175.543,66
|
|
779
|
32c
|
19999772-1
|
REVLIMID de 25 mg; TABLETA / CÁPSULA; x 21
|
CELGENE EUROPE LIMITED
|
$
15.277.978,19
|
|
780
|
32d
|
19999773-1
|
REVLIMID de 15 mg; TABLETA / CÁPSULA; x 21
|
CELGENE EUROPE LIMITED
|
$
15.033.235,92
|
|
781
|
70a
|
113757-1
|
TIMOGLOBULINA - 25 mg - POLVO RECONSTITUIR A SOLUCION /
SUSPENSION INYECTABLE x 1
|
GENZYME
|
$
532.757,92
|
|
782
|
70b
|
20024740-1
|
THYMOGAM - 250 mg - 5 mi - 50 mg/ml - SOLUCION / SUSPENSION
INYECTABLE x 1
|
BHARAT SERUMS
|
$
1.165.517,22
|
|
783
|
75a
|
19988006-1
|
TRACLEER - 62,5 mg - TABLETA / CAPSULA x 60
|
ACTELION
|
$
6.916.268,78
|
|
784
|
75b
|
19988005-1
|
TRACLEER -125 mg - TABLETA / CAPSULA x 60
|
ACTELION
|
$
6.812.885,48
|
|
785
|
85a
|
19913650-1
|
IMMUNINE - 600 Ul - POLVO RECONSTITUIRA SOLUCION /
SUSPENSION INYECTABLE x 1
|
BAXTER
|
$
612.315,64
|
|
786
|
86a
|
19904609-6
|
BENEFIX - 500 Ul - 5 ml - 100,00 Ul/ml - POLVO RECONSTITUIR
A SOLUCION / SUSPENSION INYECTABLE x 8
|
PFIZER
|
$
8.608.583,06
|
|
787
|
86a
|
201884-1
|
FANHDI - 500 Ul -10 ml - 50,00 Ul/ml - POLVO RECONSTITUIR A
SOLUCION / SUSPENSION INYECTABLE x 1
|
GRIFOLS
|
$
559.522,49
|
|
788
|
86a
|
201884-2
|
FANHDI - 500 Ul -10 ml - 50,00 Ul/ml - POLVO RECONSTITUIR A
SOLUCION / SUSPENSION INYECTABLE x 1
|
GRIFOLS
|
$
559.522,49
|
|
789
|
86a
|
35076-5
|
HEMOFIL M - 500 Ul -10 ml - 50,00 Ul/ml - POLVO
RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 1
|
BAXTER
|
$
559.522,49
|
|
790
|
86a
|
35076-6
|
HEMOFIL M - 1000 Ul -10 ml - 100,00 Ul/ml - POLVO RECONSTITUIR
A SOLUCION / SUSPENSION INYECTABLE x 1
|
BAXTER
|
$
1.119.044,99
|
|
791
|
86a
|
35076-7
|
HEMOFIL M - 1500 Ul - 10 ml - 150,00 Ul/ml - POLVO
RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 1
|
BAXTER
|
$
1.678.567,48
|
|
792
|
86a
|
35076-8
|
HEMOFIL M - 1500 Ul -10 ml - 150,00UI/ml - POLVO
RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 1
|
BAXTER
|
$
1.678.567,48
|
|
793
|
86b
|
19904609-2
|
BENEFIX - 500 Ul - 5 ml - 100,00 Ul/ml - POLVO RECONSTITUIR
A SOLUCION / SUSPENSION INYECTABLE x 1
|
PFIZER
|
$
1.076.072,88
|
|
794
|
86b
|
19904609-3
|
BENEFIX - 500 Ul - 5 ml - 100,00 Ul/ml - POLVO RECONSTITUIR
A SOLUCION / SUSPENSION INYECTABLE x 2
|
PFIZER
|
$
2.152.145,77
|
|
795
|
86b
|
19904609-4
|
BENEFIX - 500 Ul - 5 mi - 100,00 Ul/ml - POLVO RECONSTITUIR
A SOLUCION / SUSPENSION INYECTABLE x 5
|
PFIZER
|
$
5.380.364,42
|
|
796
|
86b
|
19904609-5
|
BENEFIX - 500 Ul - 5 mi - 100,00 Ul/ml - POLVO RECONSTITUIR
A SOLUCION / SUSPENSION INYECTABLE x 6
|
PFIZER
|
$
6.456.437,30
|
|
797
|
86b
|
19904609-7
|
BENEFIX - 500 Ul - 5 mi - 100,00 Ul/ml - POLVO RECONSTITUIR
A SOLUCION / SUSPENSION INYECTABLE X 10
|
PFIZER
|
$
10.760.728,83
|
|
798
|
86b
|
19904609-8
|
BENEFIX - 500 Ul - 5 mi - 100,00 Ul/ml - POLVO RECONSTITUIR
A SOLUCION / SUSPENSION INYECTABLE X 12
|
PFIZER
|
$
12.912.874,60
|
|
799
|
86b
|
19904610-1
|
BENEFIX - 250 Ul - 5 mi - 50,00 Ul/ml - POLVO RECONSTITUIR
A SOLUCION / SUSPENSION INYECTABLE x 1
|
PFIZER
|
$
538.036,44
|
|
800
|
86b
|
19904610-3
|
BENEFIX - 250 Ul - 5 mi - 50,00 Ul/ml - POLVO RECONSTITUIR
A SOLUCION / SUSPENSION INYECTABLE x 1
|
PFIZER
|
$
538.036,44
|
|
801
|
86b
|
19904610-4
|
POLVO RECONSTITUIR A SOLUCION / SUSPENSION INYECTABLE x 2
|
PFIZER
|
$
1.076.072,88
|
|
802
|
86b
|
19904610-5
|
BENEFIX - 250 Ul - 5 mi - 50,00 Ul/ml - POLVO RECONSTITUIR
A SOLUCION / SUSPENSION INYECTABLE x 5
|
PFIZER
|
$
2.690.182,21
|
|
803
|
86b
|
19904610-6
|
BENEFIX - 250 Ul - 5 mi - 50,00 Ul/ml - POLVO RECONSTITUIR
A SOLUCION / SUSPENSION INYECTABLE x 6
|
PFIZER
|
$
3.228.218,65
|
|
804
|
86b
|
19904610-7
|
BENEFIX - 250 Ul - 5 ml - 50,00 Ul/ml - POLVO RECONSTITUIR
A SOLUCION / SUSPENSION INYECTABLE x 8
|
PFIZER
|
$
4.304.291,54
|
|
805
|
86b
|
19904610-8
|
BENEFIX - 250 Ul - 5 ml - 50,00 Ul/ml - POLVO RECONSTITUIR
A SOLUCION / SUSPENSION INYECTABLE X 10
|
PFIZER
|
$
5.380.364,42
|
|
806
|
86b
|
19904610-9
|
BENEFIX - 250 Ul - 5 ml - 50,00 Ul/ml - POLVO RECONSTITUIR
A SOLUCION / SUSPENSION INYECTABLE X 12
|
PFIZER
|
$
6.456.437,30
|
